10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the quarterly period ended September 30, 2021

☐TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

Commission file number: 000-55205

 

Alpine 4 Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware	46-5482689
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
2525 E Arizona Biltmore Circle, Suite 237
Phoenix, AZ	85016
(Address of Principal Executive Offices)	(Zip Code)

Registrant's telephone number, including area code: 480-702-2431

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes ☒       No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐        No ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(1) of the Exchange Act. ☒

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date:  As of November 1, 2021, the issuer had 149,609,780 shares of its Class A common stock issued and outstanding, 8,673,088 shares of its Class B common stock issued and outstanding and 12,500,200 shares of its Class C common stock issued and outstanding.

1

TABLE OF CONTENTS

PART I		Page
Item 1.	Financial Statements	4
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28
Item 4.	Controls and Procedures	28
PART II
Item 1.	Legal Proceedings	28
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29
Item 3.	Defaults Upon Senior Securities	30
Item 5.	Other Information	30
Item 6.	Exhibits	30
	Signatures	32

2

CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS

Certain statements and information in this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 (the “Quarterly Report”) may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, which address activities, events, or developments that we expect or anticipate will or may occur in the future, including such things as future capital expenditures, commencement of business operations, business strategy, statements related to the expected effects on our business from the novel coronavirus (“COVID-19”) pandemic, and other similar matters are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “hope,” “intend,” “project,” “positioned,” or “strategy” or other comparable terminology. These forward-looking statements are based largely on our current expectations and assumptions and are subject to a number of risks and uncertainties, many of which are beyond our control. These statements are subject to many risks, uncertainties, and other important factors that could cause actual future results to differ materially from those expressed in the forward-looking statements including, but not limited to, the duration and scope of the COVID-19 pandemic and impact on the demand for the products we distribute; our ability to obtain the products from the manufacturer; actions governments, businesses, and individuals take in response to the pandemic, including mandatory business closures and restrictions on onsite commercial interactions; the impact of the COVID-19 pandemic and action taken in response to the pandemic on global and regional economies and economic activity; the pace of recovery when the COVID-19 pandemic subsides; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; our inability to sustain profitable sales growth; and circumstances or developments that may make us unable to implement or realize the anticipated benefits, or that may increase the costs, of our current and planned business initiatives. For a more thorough discussion of these risks, you should read this entire Report carefully, as well as the risks discussed under “Risk Factors” in our Annual Report for the year ended December 31, 2020.  

Although management believes that the assumptions underlying the forward-looking statements included in this Report are reasonable, such statements do not guarantee our future performance, and actual results could differ from those contemplated by these forward-looking statements. The assumptions used for purposes of the forward-looking statements specified in the following information represent estimates of future events and are subject to uncertainty as to possible changes in economic, legislative, industry, and other circumstances. As a result, the identification and interpretation of data and other information and their use in developing and selecting assumptions from and among reasonable alternatives require the exercise of judgment. To the extent that the assumed events do not occur, the outcome may vary substantially from anticipated or projected results, and, accordingly, no opinion is expressed on the achievability of those forward-looking statements. In the light of these risks and uncertainties, all of the forward-looking statements made herein are qualified by these cautionary statements, and there can be no assurance that the results and events contemplated by the forward-looking statements contained in this Report will in fact transpire. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. We expressly disclaim any obligation to update or revise any forward-looking statements.

3

PART I - FINANCIAL INFORMATION

Item 1.Financial Statements. 

ALPINE 4 HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

				September 30,		December 31,
				2021		2020
				(unaudited)
ASSETS
CURRENT ASSETS:
	Cash		$	5,425,913	$	277,738
	Restricted cash			-		444,845
	Accounts receivable, net			12,990,229		6,484,869
	Contract assets			3,655,625		717,421
	Inventory, net			9,632,121		2,666,602
	Prepaid expenses and other current assets			1,272,760		32,301
		Total current assets		32,976,648		10,623,776
Investment in equity securities				1,350,000		-
Property and equipment, net				27,320,596		19,299,286
Intangible asset, net				29,001,665		7,743,084
Right of use assets, net				347,712		581,311
Goodwill				5,866,454		2,084,982
Other non-current assets				248,257		401,744
	TOTAL ASSETS		$	97,111,332	$	40,734,183
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
	Accounts payable		$	5,653,158	$	4,854,467
	Accrued expenses			4,253,987		2,872,202
	Contract liabilities			3,486,331		233,485
	Line of credit			3,718,972		-
	Notes payable, current portion			5,811,241		7,100,911
	Notes payable, related parties			3,000		238,651
	Convertible notes payable, current portion, net of discount of $0 and $1,343,624			7,500		562,242
	Financing lease obligation, current portion			628,574		639,527
	Operating lease obligation, current portion			135,207		334,500
		Total current liabilities		23,697,970		16,835,985
Notes payable, net of current portion				7,522,462		15,201,450
Convertible notes payable, net of current portion				-		1,100,635
Financing lease obligations, net of current portion				15,489,693		15,687,176
Operating lease obligations, net of current portion				219,682		269,030
Deferred tax liability				428,199		428,199
	TOTAL LIABILITIES			47,358,006		49,522,475
STOCKHOLDERS' EQUITY (DEFICIT):
	Preferred stock, $0.0001 par value, 5,000,000 shares authorized			-		-
	Series B preferred stock; $1.00 stated value; 100 shares authorized, 5 and 5 shares issued and outstanding at September 30, 2021 and December 31, 2020			5		5
	Series C preferred stock; $3.50 stated value; 2,028,572 shares authorized, 1,714,286 and 1,714,286 shares issued and outstanding at September 30, 2021 and December 31, 2020			171		171
	Series D preferred stock; $3.50 stated value; 1,628,572 shares authorized, 1,432,244 and 0 shares issued and outstanding at September 30, 2021 and December 31, 2020			143		-
	Class A Common stock, $0.0001 par value, 195,000,000 shares authorized, 146,214,650 and 126,363,158 shares issued and outstanding at September 30, 2021 and December 31, 2020			14,624		12,636
	Class B Common stock, $0.0001 par value, 10,000,000 shares authorized, 8,673,088 and 9,023,088 shares issued and outstanding at September 30, 2021 and December 31, 2020			867		902
	Class C Common stock, $0.0001 par value, 15,000,000 shares authorized, 12,500,200 and 14,162,267 shares issued and outstanding at September 30, 2021 and December 31, 2020			1,250		1,417
	Additional paid-in capital			96,306,820		30,991,978
	Accumulated deficit			(46,570,554)		(39,795,401)
		Total stockholders' equity (deficit)		49,753,326		(8,788,292)
	TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)		$	97,111,332	$	40,734,183

The accompanying notes are an integral part of these unaudited consolidated financial statements.

4

ALPINE 4 HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

			Three Months Ended September 30,				Nine Months Ended September 30,
			2021		2020		2021		2020
Revenue		$	17,398,316	$	8,729,633	$	39,938,585	$	26,608,093
Cost of revenue			12,950,180		7,390,406		30,771,770		21,553,106
Gross Profit			4,448,136		1,339,227		9,166,815		5,054,987
Operating expenses:
	General and administrative expenses		5,539,465		1,911,278		17,719,228		7,225,280
	Impairment loss of intangible assets and goodwill		-		-		-		1,111,600
	Research and development		581,131		-		1,096,333		-
	Total operating expenses		6,120,596		1,911,278		18,815,561		8,336,880
Loss from operations			(1,672,460)		(572,051)		(9,648,746)		(3,281,893)
Other income (expenses)
	Interest expense		(537,882)		(1,139,462)		(3,226,192)		(3,694,531)
	Change in value of derivative liability		-		-		-		2,298,609
	Gain (loss) on extinguishment of debt		-		253,063		803,079		344,704
	Gain on forgiveness of debt		4,307,291		-		4,896,573		-
	Bargain purchase gain		-		64,371		-		64,371
	Change in fair value of contingent consideration		-		-		-		500,000
	Other income		438,701		(5,783)		454,191		56,352
	Total other income (expenses)		4,208,110		(827,811)		2,927,651		(430,495)
Income (loss) before income tax			2,535,650		(1,399,862)		(6,721,095)		(3,712,388)
Income tax			54,058		-		54,058		-
Net income (loss)		$	2,481,592	$	(1,399,862)	$	(6,775,153)	$	(3,712,388)
Weighted average shares outstanding:
	Basic		166,964,408		131,934,084		161,118,324		130,111,673
	Diluted		168,627,907		131,934,084		161,118,324		138,238,550
Basic income (loss) per share		$	0.01	$	(0.01)	$	(0.04)	$	(0.03)
Diluted income (loss) per share		$	0.01	$	(0.01)	$	(0.04)	$	(0.04)

The accompanying notes are an integral part of these unaudited consolidated financial statements.

5

ALPINE 4 HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

(unaudited)

	Series B Preferred Stock			Series C Preferred Stock			Series D Preferred Stock			Class A Common Stock			Class B Common Stock			Class C Common Stock				Additional Paid-in		Accumulated		Total Stockholders’
	Shares		Amount	Shares		Amount	Shares		Amount	Shares		Amount	Shares		Amount	Shares		Amount		Capital		Deficit		Deficit
Balance, December 31, 2020	5	$	5	1,714,286	$	171	-	$	-	126,363,158	$	12,636	9,023,088	$	902	14,162,267	$	1,417	$	30,991,978	$	(39,795,401)	$	(8,788,292)
Issuance of shares of common stock for cash, net of offering costs	-		-	-		-	-		-	9,857,397		985	-		-	-		-		54,301,997		-		54,302,982
Issuance of shares of common stock for convertible note payable and accrued interest	-		-	-		-	-		-	702,877		70	-		-	-		-		109,760		-		109,830
Issuance of shares of series D preferred stock for acquisition	-		-	-		-	1,432,244		143	-		-	-		-	-		-		6,653,166		-		6,653,309
Repurchase of class C common stock	-		-	-		-	-		-	-		-	-		-	(45,000)		(5)		(185,845)		-		(185,850)
Share-based compensation expense	-		-	-		-	-		-	-		-	-		-	-		-		19,341		-		19,341
Beneficial conversion feature on convertible notes	-		-	-		-	-		-	-		-	-		-	-		-		92,428		-		92,428
Net loss	-		-	-		-	-		-	-		-	-		-	-		-		-		(6,129,468)		(6,129,468)
Balance, March 31, 2021	5		5	1,714,286		171	1,432,244		143	136,923,432		13,691	9,023,088		902	14,117,267		1,412		91,982,825		(45,924,869)		46,074,280
Issuance of shares of common stock for acquisitions	-		-	-		-	-		-	643,010		64	-		-	-		-		2,535,007		-		2,535,071
Issuance of shares of common stock for convertible note payable and accrued interest	-		-	-		-	-		-	5,295,308		534	-		-	-		-		1,419,034		-		1,419,568
Conversion of Class C to Class A	-		-	-		-	-		-	1,617,067		162	-		-	(1,617,067)		(162)		-		-		-
Conversion of Class B to Class A	-		-	-		-	-		-	350,000		35	(350,000)		(35)	-		-		-		-		-
Share-based compensation expense	-		-	-		-	-		-	-		-	-		-	-		-		7,988		-		7,988
Net loss	-		-	-		-	-		-	-		-	-		-	-		-		-		(3,127,277)		(3,127,277)
Balance, June 30, 2021	5		5	1,714,286		171	1,432,244		143	144,828,817		14,486	8,673,088		867	12,500,200		1,250		95,944,854		(49,052,146)		46,909,630
Issuance of shares of common stock for convertible note payable and accrued interest	-		-	-		-	-		-	1,385,833		138	-		-	-		-		357,362		-		357,500
Share-based compensation expense	-		-	-		-	-		-	-		-	-		-	-		-		4,604		-		4,604
Net loss	-		-	-		-	-		-	-		-	-		-	-		-		-		2,481,592		2,481,592
Balance, September 30, 2021	5	$	5	1,714,286	$	171	1,432,244	$	143	146,214,650	$	14,624	8,673,088	$	867	12,500,200	$	1,250	$	96,306,820	$	(46,570,554)	$	49,753,326
Balance, December 31, 2019	-	$	-	-	$	-	-	$	-	100,070,161	$	10,007	5,000,000	$	500	9,955,200	$	996	$	19,763,883	$	(31,745,528)	$	(11,970,142)
Issuance of shares of common stock for cash	-		-	-		-	-		-	3,941,753		394	-		-	-		-		249,606		-		250,000
Issuance of shares of common stock for convertible note payable and accrued interest	-		-	-		-	-		-	4,648,879		464	-		-	-		-		696,868		-		697,332
Issuance of shares of common stock for debt settlement	-		-	-		-	-		-	1,617,067		162	-		-	1,617,067		162		330,204		-		330,528
Issuance of shares of common stock for penalty	-		-	-		-	-		-	300,000		30	-		-	-		-		44,670		-		44,700
Issuance of shares of common stock for compensation	-		-	-		-	-		-	-		-	4,023,088		402	-		-		603,061		-		603,463
Issuance of shares of series B preferred stock	5		5	-		-	-		-	-		-	-		-	-		-		-		-		5
Share-based compensation expense	-		-	-		-	-		-	-		-	-		-	-		-		19,556		-		19,556
Net income	-		-	-		-	-		-	-		-	-		-	-		-		-		250,388		250,388
Balance, March 31, 2020	5		5	-		-	-		-	110,577,860		11,057	9,023,088		902	11,572,267		1,158		21,707,848		(31,495,140)		(9,774,170)
Share-based compensation expense	-		-	-		-	-		-	-		-	-		-	-		-		19,556		-		19,556
Net loss	-		-	-		-	-		-	-		-	-		-	-		-		-		(2,562,914)		(2,562,914)
Balance, June 30, 2020	5		5	-		-	-		-	110,577,860		11,057	9,023,088		902	11,572,267		1,158		21,727,404		(34,058,054)		(12,317,528)
Issuance of shares of common stock for cash	-		-	-		-	-		-	3,000,000		300	-		-	-		-		123,700		-		124,000
Share-based compensation expense	-		-	-		-	-		-	-		-	-		-	-		-		19,770		-		19,770
Net loss	-		-	-		-	-		-	-		-	-		-	-		-		-		(1,399,862)		(1,399,862)
Balance, September 30, 2020	5	$	5	-	$	-	-	$	-	113,577,860	$	11,357	9,023,088	$	902	11,572,267	$	1,158	$	21,870,874	$	(35,457,916)	$	(13,573,620)

The accompanying notes are an integral part of these unaudited consolidated financial statements.

6

ALPINE 4 HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

					Nine Months Ended September 30,
					2021		2020
OPERATING ACTIVITIES:
	Net loss			$	(6,775,153)	$	(3,712,388)
	Adjustments to reconcile net loss to net cash used in operating activities:
		Depreciation and amortization			2,851,969		1,582,604
		Gain on extinguishment of debt			(803,079)		(344,704)
		Gain of forgiveness of debt			(4,896,573)		-
		Change in fair value of contingent consideration			-		(500,000)
		Change in fair value of derivative liabilities			-		(2,298,609)
		Stock issued for penalties			-		44,700
		Employee stock compensation			31,933		58,887
		Amortization of debt discounts			1,436,052		507,534
		Non-cash lease expense			328,628		200,165
		Bargain purchase gain			-		(64,371)
		Impairment loss of intangible asset and goodwill			-		1,111,600
		Write off of inventory			-		127,919
		Change in current assets and liabilities:
			Accounts receivable		(6,096,678)		2,542,306
			Inventory		(4,343,866)		(146,925)
			Contract assets		(2,111,973)		158,978
			Prepaid expenses and other assets		(696,471)		141,147
			Accounts payable		(17,460)		(661,933)
			Accrued expenses		1,045,007		159,828
			Contract liabilities		(835,632)		(71,548)
			Operating lease liability		(343,670)		(189,503)
			Deposits		-		(12,509)
	Net cash used in operating activities				(21,226,966)		(1,366,822)
INVESTING ACTIVITIES:
		Capital expenditures			(2,970,087)		(75,670)
		Cash paid for equity investment			(350,000)		-
		Cash paid for acquisitions			(16,824,000)		(2,513,355)
		Cash assumed in acquisition			81,442		-
	Net cash used in investing activities				(20,062,645)		(2,589,025)
FINANCING ACTIVITIES:
		Proceeds from the sale of common stock, net of offering costs			54,302,982		374,000
		Proceeds from issuances of notes payable, related parties			-		47,000
		Proceeds from issuances of notes payable, non-related party			15,609		4,644,817
		Proceeds from issuances of convertible notes payable			408,000		-
		Proceeds from line of credit			3,718,972		-
		Proceeds from financing lease			-		2,000,000
		Repurchase of common stock			(185,850)		-
		Repayments of notes payable, related party			(235,651)		(217,822)
		Repayments of notes payable, non-related parties			(7,041,401)		(1,745,647)
		Repayments of convertible notes payable			(1,680,964)		(270,294)
		Repayment of line of credit			(2,821,033)		(660,764)
		Cash paid on financing lease obligations			(487,723)		(355,094)
	Net cash provided by financing activities				45,992,941		3,816,196
NET INCREASE (DECREASE) IN CASH AND RESTRICTED CASH					4,703,330		(139,651)
CASH AND RESTRICTED CASH, BEGINNING BALANCE					722,583		302,486
CASH AND RESTRICTED CASH, ENDING BALANCE				$	5,425,913	$	162,835
CASH PAID FOR:
	Interest			$	1,593,255	$	2,857,895
	Income taxes			$	54,058	$	-
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING AND INVESTING:
	Penalty interest added to debt			$	-	$	15,000
	Common stock issued for convertible note payable and accrued interest			$	1,886,898	$	697,332
	Common stock issued for debt settlement			$	-	$	330,528
	Issuance of note payable for acquisition			$	-	$	2,300,000
	Common stock issued for acquisition			$	2,535,071	$	-
	Common stock issued to settle unpaid salaries			$	-	$	603,463
	ROU asset and operating lease obligation recognized under Topic 842			$	95,029	$	193,541
	Remeasurement of finance lease liability			$	279,287	$	-
	Equipment purchased on financing lease			$	-	$	756,990
	Mortgage on property purchase			$	4,680,000	$	-
	Accounts receivable converted to equity investment			$	1,000,000	$	-
	Other asset reclassified to fixed asset			$	-	$	86,471
	Issuance of shares of series D preferred stock for acquisition			$	6,653,309	$	-
	Interest added to note payable – related party			$	-	$	134,185
	Beneficial conversion feature on convertible notes			$	92,428	$	-

The accompanying notes are an integral part of these unaudited consolidated financial statements.

7

Alpine 4 Holdings, Inc., and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

For the Nine Months Ended September 30, 2021

Note 1 – Organization and Basis of Presentation

The unaudited consolidated financial statements were prepared by Alpine 4 Holdings, Inc. (‘we,” “our,” or the "Company"), pursuant to the rules and regulations of the Securities Exchange Commission ("SEC"). The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") were omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company's Annual Report on Form 10-K filed with the SEC on April 15, 2021. The results for the nine months ended September 30, 2021, are not necessarily indicative of the results to be expected for the year ending December 31, 2021.

The Company was incorporated under the laws of the State of Delaware on April 22, 2014.  The Company was formed to serve as a vehicle to affect an asset acquisition, merger, exchange of capital stock, or other business combination with a domestic or foreign business.  On March 2, 2021, the Company changed its name from Alpine 4 Technologies Ltd. to Alpine 4 Holdings, Inc.

Effective April 1, 2016, the Company purchased all of the outstanding capital stock of Quality Circuit Assembly, Inc., a California corporation (“QCA”).

Effective January 1, 2019, the Company purchased all of the outstanding capital stock or equity interests in Morris Sheet Metal Corp., an Indiana corporation (“MSM”); JTD Spiral, Inc., an Indiana corporation wholly owned by MSM; Morris Enterprises LLC, an Indiana limited liability company; and Morris Transportation LLC, an Indiana limited liability company (collectively “Morris”).

Effective November 6, 2019, the Company purchased all of the outstanding capital stock and units of Deluxe Sheet Metal, Inc., an Indiana corporation, and DSM Holding, LLC, an Indiana limited liability company; and purchased certain real estate from Lonewolf Enterprises, LLC, an Indiana limited liability company (collectively “Deluxe”).

Effective February 21, 2020, the Company purchased all of the outstanding units of Excel Fabrication, LLC., an Idaho limited liability company (“Excel”).  Excel subsequently changed its name to Excel Construction Services, LLC.

Effective December 15, 2020, the Company purchased the assets of Impossible Aerospace Corporation, a Delaware corporation (“IA”).

Effective February 8, 2021, the Company purchased the assets of Vayu (US), Inc., a Delaware corporation (“Vayu”).

On May 5, 2021, the Company acquired all of the outstanding shares of stock of Thermal Dynamics, Inc., a Delaware corporation (“TDI”).

On May 10, 2021, the Company acquired all of the outstanding membership interests of KAI Enterprises, LLC, a Florida limited liability company, the sole asset of which was all of the outstanding membership interests of Alternative Laboratories, LLC, a Delaware limited liability company (“Alt Labs”).

On October 20, 2021, after the period covered by this Report, the Company acquired 100% of the outstanding shares of Identified Technologies Corporation, a Delaware corporation (“Identified Technologies”).

As of the date of this Report, the Company was a holding company owning, directly or indirectly, eleven companies:

·A4 Corporate Services, LLC;  

·ALTIA, LLC;  

·Quality Circuit Assembly, Inc.;  

·Morris Sheet Metal, Corp;  

·JTD Spiral, Inc.;  

·Excel Construction Services, LLC;  

·SPECTRUMebos, Inc.;  

·Vayu (US); 

·Thermal Dynamics, Inc.; 

·Alternative Laboratories, LLC.; and 

·Identified Technologies Corporation. 

8

Basis of presentation

The accompanying consolidated financial statements present the balance sheets, statements of operations, stockholders' deficit and cash flows of the Company. The financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”).

Liquidity

The Company’s financial statements are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued.

In accordance with Financial Accounting Standards Board (the “FASB”), Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

While the Company experienced a loss for the nine months ended September 30, 2021, of $6.8 million, and had a negative cash flow used in operations, there were several significant one-time / non-recurring items included in the $6.8 million net loss.  These non-recurring items totaled $2.2 million, consisting of $350 thousand in new acquisitions expenses captured in professional fees, and other costs, and $1.8 million for repurchase of RSUs.

The Company received a total of approximately $54.0 million in February 2021 in the following two transactions:

·The Company raised approximately $45.0 million in net proceeds in connection with a registered direct offering of its stock and;  

·The Company raised approximately $9.0 million in net proceeds in connection with an equity line of credit financing arrangement.  

The Company has secured bank financing totaling $9.3 million ($8.3 million in Lines of Credit and $1.0 million in capital expenditures lines of credit availability) of which $5.6 million was unused at September 30, 2021.

The Company plans to continue to generate additional revenue (and improve cash flows from operations) partly from the acquisitions of three operating companies which closed in May 2021 and October 2021 combined with improved gross profit performance from the existing operating companies.

Based on the capital raise as indicated above and management’s plans to improve cash flows from operations, management believes the Company has sufficient working capital to satisfy the Company’s estimated liquidity needs for the next 12 months. The Company ended the September 30, 2021, quarter with approximately $5.4 million in cash and working capital of $9.3 million. As of the date of this Report, the Company had approximately $3.5 million in cash. During the nine months ended September 30, 2021, the Company paid down liabilities of approximately $13.1 million. In addition, approximately $7.2 million was used to build inventory and for capital expenditures.

However, there is no assurance that management’s plans will be successful due to the current economic climate in the United States and globally.

Note 2 - Summary of Significant Accounting Policies

Principles of consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of September 30, 2021 and December 31, 2020.  Significant intercompany balances and transactions have been eliminated.

Use of estimates

The consolidated financial statements are prepared in accordance with U.S. GAAP.  Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. In many instances, the Company could have reasonably used different accounting estimates and in other instances changes in the accounting estimates are reasonably likely to occur from period to period. This applies in particular to useful lives of long-lived assets, valuation allowance for deferred tax assets and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial

9

statement presentation, financial condition, results of operations and cash flows will be affected.  The ultimate impact from COVID-19 on the Company’s operations and financial results during 2021 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, and the speed with which the economy recovers. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during 2021 and beyond.  COVID-19 did have a negative impact on the Company’s financial performance in 2020.  During the nine months ended September 30, 2021, there was no impairment charge related to intangible assets and goodwill.

Cash and Restricted Cash

Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. As of September 30, 2021, and December 31, 2020, the Company had no cash equivalents. As of September 30, 2021, and December 31, 2020, the Company had $0 and $444,845 in restricted cash, respectively, for amounts held in escrow.

The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows.

		September 30,		December 31,
		2021		2020
Cash	$	5,425,913	$	277,738
Restricted cash		-		444,845
Total cash and restricted cash shown in statement of cash flows	$	5,425,913	$	722,583

Major Customers

The Company had two customers that made up 16% and 18%, respectively, of accounts receivable as of September 30, 2021. The Company had two customers that made up 10% and 8%, respectively, of accounts receivable as of December 31, 2020.

For the nine months ended September 30, 2021 and 2020, the Company had one customer that made up 13% and 10% of total revenues, respectively.

Fair value measurements

Accounting Standards Codification (“ASC”)  820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.

The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates.  As of September 30, 2021 and December 31, 2020, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis.

Equity Investments

The Company’s equity investments consist of investment in one private company in which the Company does not have the ability to exercise significant influence over their operating and financial activities. This investment is carried at cost as there is no market for the common stock and LLC membership units, accordingly, no quoted market price is available. The investment is tested for impairment, at least annually, and more frequently upon the occurrences of certain events.

10

The Company has adopted the provisions of ASU 2016-01 and values the investment using the measurement alternative, defined as cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.

Research and Development

The Company focuses on quality control and development of new products and the improvement of existing products. All cost related to research and development activities are expensed as incurred. During the nine months ended September 30, 2021, research and development cost totaled $1,096,333.

Earnings (loss) per shares

The Company presents both basic and diluted net income (loss) per share on the face of the consolidated statements of operations. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, and using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The only potentially dilutive securities outstanding during the periods presented were the convertible debt, options and warrants.  The following table illustrates the computation of basic and diluted earnings per share (“EPS”) for the three and nine months ended September 30, 2021 and 2020:

		For the Three Months Ended September 30, 2021				For the Three Months Ended September 30, 2020
		Net Income	Shares		Per Share Amount		Net loss	Shares		Per Share Amount
Basic EPS
Net income (loss)	$	2,481,592	166,964,408	$	0.01	$	(1,399,862)	131,934,084	$	(0.01)
Effect of Dilutive Securities
Stock options and warrants		-	1,663,499		-		-	-		-
Dilute EPS
Net income (loss) plus
assumed conversions	$	2,481,592	168,627,907	$	0.01	$	(1,399,862)	131,934,084	$	(0.01)

		For the Nine Months Ended September 30, 2021				For the Nine Months Ended September 30, 2020
		Net loss	Shares		Per Share Amount		Net loss	Shares		Per Share Amount
Basic EPS
Net loss	$	(6,775,153)	161,118,324	$	(0.04)	$	(3,712,388)	130,111,673	$	(0.03)
Effect of Dilutive Securities
Convertible debt		-	-		-		(1,557,294)	8,126,877		(0.01)
Dilute EPS
Net loss plus
assumed conversions	$	(6,775,153)	161,118,324	$	(0.04)	$	(5,269,682)	138,238,550	$	(0.04)

11

Note 3 – Leases

The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company must discount lease payments based on an estimate of its incremental borrowing rate.

As of September 30, 2021, the future minimum finance and operating lease payments were as follows:

		Finance		Operating
Twelve Months Ending September 30,		Leases		Leases
2022	$	1,895,925	$	175,319
2023		1,923,246		104,648
2024		1,946,100		106,680
2025		1,911,278		53,848
2026		1,859,102		-
Thereafter		17,239,539		-
Total payments		26,775,190		440,495
Less: imputed interest		(10,656,923)		(85,606)
Total obligation		16,118,267		354,889
Less: current portion		(628,574)		(135,207)
Non-current financing leases obligations	$	15,489,693	$	219,682

As of October 1, 2020, the American Precision Fabricators, Inc. (“APF”) building lease with Harbor Island Properties, LLC was modified, assignment was transferred to Excel Fabrication, LLC (“Excel”), and Quality Circuit Assembly, Inc. (“QCA”). As part of the modification, the lease was extended through 2037 and the payment terms were amended effective January 15, 2021. As a result of this amendment, the Company remeasured the finance lease liability and recorded an additional $279,287 to the related asset and finance lease liability on the date of the modification.

Operating Leases

The table below presents the lease related assets and liabilities recorded on the Company’s consolidated balance sheets as of September 30, 2021, and December 31, 2020:

			September 30,		December 31,
	Classification on Balance Sheet		2021		2020
Assets
Operating lease assets	Operating lease right of use assets	$	347,712	$	581,311
Total lease assets		$	347,712	$	581,311
Liabilities
Current liabilities
Operating lease liability	Current operating lease liability	$	135,207	$	334,500
Noncurrent liabilities
Operating lease liability	Long-term operating lease liability		219,682		269,030
Total lease liability		$	354,889	$	603,530

On May 3, 2021, the Company entered into a lease agreement for the building on 4740 Cleveland in Ft. Myers, Fl. The lease has a term of 72 months with monthly payments ranging from $40,833 to $49,583 from May 2021-July 2021 and $58,333 from August 2021 through the end of the term. The Company determined the lease to be an operating lease and recognized a right-of-use asset and operating lease liability of $3,689,634 based on the present value of the minimum lease payments discounted using an incremental borrowing rate of 3.96%. This lease was terminated on August 27, 2021, when the Company purchased the building.

At September 30, 2021 and December 31, 2020, the weighted average remaining lease terms were 2.88 and 2.98 years; respectively, and the weighted average discount rates were 15% and 15%, respectively.

12

Note 4 – Notes Payable and Line of Credit

The outstanding balances for the loans as of September 30, 2021, and December 31, 2020, were as follows:

		September 30,		December 31,
		2021		2020
Lines of credit, current portion	$	3,718,972	$	2,819,793
Equipment loans, current portion		63,531		245,388
PPP loans		278,867		-
Term notes, current portion		5,468,843		4,035,730
Total current		9,530,213		7,100,911
PPP/EIDL loans		877,083		4,340,956
Long-term portion of equipment loans and term notes		6,645,379		10,860,494
Total notes payable and line of Credit	$	17,052,675	$	22,302,361

Future scheduled maturities of outstanding notes payable are as follows:

Twelve Months Ending September 30,
2022	$	9,530,212
2023		933,846
2024		2,183,157
2025		125,699
2026		130,755
Thereafter		4,149,006
Total	$	17,052,675

During the nine months ended September 30, 2021, the Company received forgiveness on nine loans under the Paycheck Protection Program (“PPP”) of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act. The Company recognized a gain on forgiveness of debt of $4,896,573.   

In connection with the Deluxe acquisition in November 2019, the Company issued two subordinated secured promissory notes to the seller.  The first note for $1,900,000 bears interest at 4.25% per annum, require monthly payment for the first 35 months of $19,463 with any remaining principal and accrued interest due on the 3 year-anniversary.  The second note for $496,343 bore interest at 8.75% matured in January 2020 and was fully settled through a debt conversion agreement with the seller.  On April 8, 2021, the Company entered into a settlement agreement with the seller wherein the outstanding balance on the first note amounting to $1,883,418 including accrued interest and net other costs was settled in full through a payment of approximately $887,000 and the exchange of 1,617,067 shares of the Company’s Class C common shares held by the seller for the same number of shares of the Company’s Class A common stock. The Company recognized a gain on extinguishment of debt totaling $803,079 during the nine months ended September 30, 2021, as a result of the settlement of the note.

In August 2020, the company filed a lawsuit against Alan Martin regarding his note payable (See Note 11). As of September 30, 2021, the note had a balance of $2,857,500 and accrued interest of $1,091,212 which is reflective in the current liabilities.

During 2021, the Company entered into three revolving lines of credit totaling $8.3 million and two capital expenditures lines of credit totaling $1.0 million. The revolving lines of credit used as of September 30, 2021, totaled $3.7 million with an interest rate ranging from prime plus 2.50% - 4.25% and a term of one year. As of September 30, 2021, the Company had $5.6 in additional funds available to borrow.

On August 27, 2021 the Company entered into $4.7 million agreement for the purchase of a building located at 4740 Cleveland in Ft. Myers, Florida. The loan bears interest at a rate of 3.95% per annum for a term of 10 years and requires monthly payments of $24,574. The loan is secured by the building and a guarantee by the Company. As of September 30, 2021, there were no payments made for this loan as the initial payment was due in October 2021, and subsequent payments are due by the 27th of each month. As of the date of this Report, the Company was current with this obligation.

13

Note 5 – Notes Payable, Related Parties

At September 30, 2021, and December 31, 2020, notes payable due to related parties consisted of the following:

		September 30,		December 31,
		2021		2020
Notes payable; non-interest bearing; due upon demand; unsecured	$	3,000	$	3,000
Series of notes payable, bearing interest at rates from 0% to 20% per annum, with maturity dates from April 2018 to July 2021, unsecured		-		235,651
Total notes payable - related parties	$	3,000	$	238,651

Two non-interest-bearing notes totaling $3,000 were in default as of September 30, 2021. These notes were due on demand by the lenders as of the date of this Report.

Note 6 – Convertible Notes Payable

At September 30, 2021, and December 31, 2020, convertible notes payable consisted of the following:

		September 30,		December 31,
		2021		2020
Series of convertible notes payable issued prior to December 31, 2016, bearing interest at rates of 8% - 10% per annum, with due dates ranging from December 2016 through June 2017.  The outstanding principal and interest balances are convertible into shares of Class A common stock at the option of the debt holder at exercise price of $1 per share.	$	7,500	$	25,000
Secured convertible notes payable issued to the sellers of QCA on April 1, 2016 for an aggregate of $2,000,000, bearing interest at 5% per annum, due in monthly payments starting on July 1, 2016 and due in full on July 1, 2019.  On August 6 and 11, 2019, the Company extended the due date of the two notes to December 31, 2020 and December 31, 2022, respectively.  In May and June 2020, these convertible notes were amended — see (A) below. The outstanding principal and interest balances were fully paid during the nine months ended September 30, 2021.		-		1,291,463
On December 7, 2018, the Company entered into a variable convertible note for $130,000 with net proceeds of $122,200.  The note is due September 7, 2019 and bears interest at 12% per annum.  The note is immediately convertible into shares of the Company's Class A common stock at a discount of 40% to the lowest trading closing prices of the stock for 20 days prior to conversion. This note was amended in November 2019 to increase the principal amount by $180,000 due to penalty interest; increase the interest rate to 15% and effect a floor in the conversion price of $0.15 per share. The outstanding principal and interest balance of the note was converted during the nine months ended September 30, 2021.		-		7,538
On November 14, 2019, the Company issued a convertible note for $200,000.  The note is due November 13, 2020 and bears interest at 15% per annum.  The note is immediately convertible into shares of the Company's Class A common stock at a fixed price of $0.15 per share. The outstanding principal balance of the note was converted during the nine months ended September 30, 2021.		-		200,000
In December 2020 and January 2021, the Company issued convertible notes to individual investors totaling to $1,890,500.  The notes are due three to six months from the date of issuance; accrue interest at 5 – 6.25% per annum and are convertible into shares of the Company's Class A common stock at a fixed rate of $0.25 to $3.00. The outstanding principal balance of the notes were converted during the nine months ended September 30, 2021.		-		1,482,500
Total convertible notes payable		7,500		3,006,501
Less: discount on convertible notes payable		-		(1,343,624)
Total convertible notes payable, net of discount		7,500		1,662,877
Less: current portion of convertible notes payable		(7,500)		(562,242)
Long-term portion of convertible notes payable	$	-	$	1,100,635

In May and June 2020 the Company amended the following seller notes:

-The convertible note with Jeff Moss with a $720,185 balance as of May 4, 2020, was amended to extend the maturity date to May 4, 2027, at 5% interest with weekly payments of $2,605.   The principal balance was increased to $798,800 and the balance outstanding at December 31, 2020, was $735,329.  

-The convertible note with Dwight Hargreaves with a $551,001 balance as of June 5, 2020, was amended to extend the maturity date to June 5, 2026, at 6% interest with weekly payments of $2,316.  The principal balance was increased to $605,464 and the balance outstanding at September 30, 2021 and December 31, 2020, was $0 and $556,135, respectively.   

14

A loss on extinguishment of debt of $192,272 was recognized on these transactions in June 2020.   

During the nine months ended September 30, 2021, and the year ended December 31, 2020, the Company issued convertible notes with fixed conversion prices.  The Company recognized a beneficial conversion feature related to these convertible notes amounting to $92,428 and $1,482,500 for the nine months ended September 30, 2021, and the year ended December 31, 2020, respectively, as a debt discount to the convertible notes and as a component of equity.  The discounts are being amortized over the terms of the convertible notes payable.  Amortization of debt discounts during the nine months ended September 30, 2021 and 2020, amounted to $1,436,052 and $507,534, respectively, and is recorded as interest expense in the accompanying consolidated statements of operations.  There was no remaining unamortized discount balance for these notes as of September 30, 2021.

A summary of the activity in the Company's convertible notes payable is provided below:

Balance outstanding, December 31, 2020	$	1,662,877
Issuance of convertible notes payable for cash		408,000
Repayment of notes		(1,680,964)
Conversion of notes payable to common stock		(1,726,037)
Amortization of debt discounts		1,436,052
Discount from beneficial conversion feature		(92,428)
Balance outstanding, September 30, 2021	$	7,500

Note 7 – Stockholders' Equity

Common Stock

The Company had the following transactions in its common stock during the nine months ended September 30, 2021:

·On February 11, 2021, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors to purchase 8,333,333 shares of the Company’s Class A common stock for aggregate gross proceeds of approximately $50 million.  A.G.P./Alliance Global Partners served as the placement agent and received a cash fee of 7% of the aggregate gross proceeds and warrants to purchase shares of the Company’s Class A Common Stock equal to 5% of the number of shares sold in the offering with an exercise price of $6.60 per share and are not exercisable until August 16, 2021. Net proceeds from the sale of shares amounted to approximately $45 million.  

·In February 2021, the Company issued 1,524,064 shares of Class A common stock to an investor for cash for total proceeds of $9.3 million.   

·During the nine months ended September 30, 2021, the Company issued 7,384,018 shares of Class A common stock for the conversion of total debt and accrued liabilities totaling $1,886,898.   

·On March 17, 2021, the Company repurchased 45,000 shares of Class C common stock for $185,850.  

·On May 5, 2021, the Company issued 281,223 shares of Class A common stock that were valued at $1,102,394 in connection with the acquisition of TDI. 

·On May 10, 2021, the Company issued 361,787 shares of Class A common stock that were valued at $1,432,677 in connection with the acquisition of Alt Labs. 

·On April 30, 2021, the Company issued 1,617,067 shares of Class A common stock for no additional consideration upon conversion of that number of shares of Class C common stock by the holder of the Class C common stock. 

·On May 17, 2021, the Company issued 350,000 shares of Class A common stock for no additional consideration upon conversion of that number of shares of Class B common stock by the holder of the Class B common stock. 

Preferred Stock

·On February 8, 2021, the Company issued 1,432,244 shares of Series D Preferred Stock in connection with the acquisition of assets of Vayu that were valued at $6,653,309.  

·In March 2021, the Company repurchased 514,286 outstanding restricted stock units (RSUs) which had not yet settled, from two individuals in privately negotiated transactions. The Company repurchased 314,286 shares of Series C Preferred Stock and 200,000 shares of Series D Preferred Stock at $3.50 per share. The RSUs had been issued to the individuals in connection with the IA and Vayu acquisitions. 

15

Stock Options

The following summarizes the stock option activity for the nine months ended September 30, 2021:

				Weighted-
			Weighted-	Average
			Average	Remaining		Aggregate
			Exercise	Contractual		Intrinsic
	Options		Price	Life (Years)		Value
Outstanding at December 31, 2020	1,790,000	$	0.19	7.09	$	6,176,855
Granted	-
Forfeited	-
Exercised	-
Outstanding at September 30, 2021	1,790,000	$	0.19	6.34	$	3,599,255
Vested and expected to vest
at September 30, 2021	1,790,000	$	0.19	6.34	$	3,599,255
Exercisable at September 30, 2021	1,556,126	$	0.21	6.27	$	3,097,221

The following table summarizes information about options outstanding and exercisable as of September 30, 2021:

	Options Outstanding			Options Exercisable
		Weighted	Weighted		Weighted
		Average	Average		Average
Exercise	Number	Remaining	Exercise	Number	Exercise
Price	of Shares	Life (Years)	Price	of Shares	Price
0.05	979,000	6.88	0.05	761,063	0.05
0.10	85,000	6.53	0.10	69,063	0.10
0.13	388,500	5.84	0.13	388,500	0.13
0.26	114,000	5.59	0.26	114,000	0.26
0.90	223,500	5.52	0.90	223,500	0.90
	1,790,000			1,556,126

During the nine months ended September 30, 2021 and 2020, stock option expense amounted to $31,933 and $58,887, respectively. Unrecognized stock option expense as of September 30, 2021, amounted to $11,815, which will be recognized over a period extending through December 2022.    

Warrants

The following summarizes the warrants activity for the nine months ended September 30, 2021:

				Weighted-
			Weighted-	Average
			Average	Remaining		Aggregate
			Exercise	Contractual		Intrinsic
	Warrants		Price	Life (Years)		Value
Outstanding at December 31, 2020	275,000	$	1.01	0.23	$	723,250
Granted	416,667		6.60
Forfeited	(275,000)		1.01
Exercised	-
Outstanding at September 30, 2021	416,667	$	6.60	3.39	$	-
Vested and expected to vest
at September 30, 2021	416,667	$	6.60	3.39	$	-
Exercisable at September 30, 2021	-	$	-	-	$	-

16

The following table summarizes information about warrants outstanding and exercisable as of September 30, 2021:

		Warrants Outstanding				Warrants Exercisable
			Weighted		Weighted			Weighted
			Average		Average			Average
	Exercise	Number	Remaining		Exercise	Number		Exercise
	Price	of Shares	Life (Years)		Price	of Shares		Price
$	6.60	416,667	3.39	$	6.60	-	$	-
		416,667				-

During the nine months ended September 30, 2021, the Company issued 416,667 warrants to a placement agent in connection with sale of its common stock. The warrants have an exercise price of $6.60, are exercisable as of August 16, 2021 and expire on February 16, 2025.

The fair value of the 416,667 warrants, issued to the placement agent during the nine months ended September 30, 2021, of $2,498,637 was determined using the Black-Scholes option pricing model with the following assumptions:

Stock price	$6.00
Risk-free interest rate	0.01%
Expected life of the options	4 years
Expected volatility	347%
Expected dividend yield	0%

The fair value of the warrants was recorded as offering costs with a corresponding credit to additional paid in capital.

Note 8 – Business Combinations

Vayu (US)

Effective February 8, 2021, the Company purchased the assets of Vayu (US), Inc., a Delaware corporation (“Vayu”).

Under the provision of ASC 805, the Company had to determine whether this acquisition was a business combination or an asset (or a group of assets) acquisition. In doing so, the Company determined that the acquisition of Vayu was in fact an asset purchase.  Of the consideration given for the Vayu acquisition more than 95% was concentrated in a single asset or a group of assets in Intellectual Property. As such, the Company accounted for this acquisition as an asset acquisition in accordance with ASC 805-10-20.  Accordingly, the assets acquired are initially recognized at the consideration paid, which was the fair value of the series D preferred stock issued, including direct acquisition costs, of which there were none. The cost is allocated to the group of assets acquired based on their relative fair values. The assets acquired and liabilities assumed were as follows at the acquisition date:

		Purchase Allocation
Cash	$	81,442
Property and equipment		50,000
Intellectual property		6,981,256
Non-solicitation covenant		90,000
Accrued expenses and other current liabilities		(411,539)
SBA loan (PPP funds)		(137,850)
	$	6,653,309

The purchase price was paid as follows:

Series D Preferred Stock	$	6,653,309
	$	6,653,309

17

TDI

On May 5, 2021, the Company closed on the acquisition of Thermal Dynamics, Inc., a Delaware corporation. This acquisition was considered an acquisition of a business under ASC 805. A summary of the purchase price allocation at fair value is below. The business combination accounting is not yet complete and the amounts assigned to assets acquired and liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as information is obtained about facts and circumstances that existed at the acquisition date.

		Purchase Allocation
Accounts receivable	$	1,408,682
Contract assets		826,231
Property and equipment		111,789
Intangible assets		4,820,000
Goodwill		3,528,621
Accounts payable		(786,151)
Accrued expenses and other current liabilities		(53,857)
Contract liability		(2,334,188)
Notes payable		(64,733)
	$	7,456,394

The purchase price was paid as follows:

Class A Common Stock	$	1,102,394
Cash		6,354,000
	$	7,456,394

Alt Labs

On May 10, 2021, the Company closed on the acquisition of Alternative Laboratories, LLC., a Delaware limited liability company. This acquisition was considered an acquisition of a business under ASC 805. A summary of the purchase price allocation at fair value is below. The business combination accounting is not yet complete and the amounts assigned to assets acquired and liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as information is obtained about facts and circumstances that existed at the acquisition date.

		Purchase Allocation
Accounts receivable	$	397,441
Inventory		2,621,653
Property and equipment		1,739,441
Intangible assets		10,410,000
Goodwill		252,851
Other asset		390,502
Accounts payable		(397,441)
Accrued expenses and other current liabilities		(62,242)
Contract liability		(1,754,290)
Noted payable		(1,695,238)
	$	11,902,677

The purchase price was paid as follows:

Class A Common Stock	$	1,432,677
Cash		10,470,000
	$	11,902,677

On May 4, 2021, the Company also entered into an agreement to acquire the 100% membership interest in 4740 Cleveland LLC (“Cleveland”), a Florida limited liability company that is the owner of the building currently being leased by Alt Labs, for a total purchase price of $7,000,000. In connection with this agreement, the Company placed in escrow the amount of $1,400,000 which will be applied to the purchase price upon closing. The Company closed on the purchase of the building in August 2021.

18

The following are the unaudited pro forma results of operations for the nine months ended September 30, 2021 and 2020, as if Excel, Impossible Aerospace, Inc. (“IA”), Vayu, TDI, and Alt Labs had been acquired on January 1, 2020.  The pro forma results include estimates and assumptions which management believes are reasonable.  However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of these entities, and are not necessarily indicative of the results that would have occurred if the business combination had been in effect on the dates indicated.

		Pro Forma Combined Financials (unaudited)
		Three Months Ended September 30,				Nine Months Ended September 30,
		2021		2020		2021		2020
Sales	$	17,398,316	$	16,299,024	$	49,465,682	$	51,377,078
Cost of goods sold		12,104,134		12,020,468		35,183,907		37,090,187
Gross profit		5,294,182		4,278,556		14,281,775		14,286,891
Operating expenses		6,966,642		4,855,978		21,474,825		17,294,094
Loss from operations		(1,672,460)		(577,422)		(7,193,050)		(3,007,203)
Net income (loss)		2,481,592		(809,618)		(3,892,897)		(2,742,963)
Net income (loss) per share		0.01		(0.01)		(0.02)		(0.02)

Note 9 – Equity Investments

AmplifeiIntl LLC

On September 15, 2021, A4 Manufacturing, Inc. entered into a Membership Interest Purchase Agreement acquiring approximately a 9% membership interest in AmplifeiIntl LLC (also doing business as Happinss), a Texas limited liability company. The membership interest is non-voting and the Company does not have the ability to exercise significant influence over operating and financial activities. The equity investment is being valued using cost as there is no market for the membership units, and accordingly, no quoted market price is available. The investment is tested for impairment, at least annually, and more frequently upon the occurrences of certain events. As of September 30, 2021, the Company determined there was no impairment.

The membership interest was paid for as follows:    

Accounts receivable converted	$	1,000,000
Cash		350,000
Total	$	1,350,000

Note 10 – Segment Reporting

The Company discloses segment information that is consistent with the way in which management operates and views its business.  Effective during the quarter ended September 30, 2021, the Company has reduced its reportable segments to four operating segments as represented by the Company’s four silos: A4 Construction Services, Inc.; A4 Manufacturing, Inc.; A4 Aerospace Corporation; and A4 Defense Systems, Inc.  The Company’s reportable segments for the three and nine months ended September 30, 2021, and September 30, 2020, and as of September 30, 2021 and December 31, 2020:

			Three Months Ended September 30,				Nine Months Ended September 30,
			2021		2020		2021		2020
Revenue
	Construction Services	$	5,465,881	$	5,488,718	$	15,565,332	$	17,198,134
	Manufacturing		10,210,549		3,240,915		21,506,262		9,409,959
	Defense		1,721,886		-		2,866,991		-
		$	17,398,316	$	8,729,633	$	39,938,585	$	26,608,093
Gross profit
	Construction Services	$	678,702	$	343,965	$	1,392,904	$	2,753,554
	Manufacturing		3,128,290		995,262		6,672,549		2,301,433
	Defense		641,144		-		1,101,362		-
		$	4,448,136	$	1,339,227	$	9,166,815	$	5,054,987
Income (loss) from operations
	Construction Services	$	(607,794)	$	(529,896)	$	(3,464,327)	$	(195,470)
	Manufacturing		947,792		392,029		1,679,930		(886,867)
	Aerospace		(963,134)		-		(3,886,311)		-
	Defense		(135,575)		-		(131,953)		-
	Unallocated		(913,749)		(434,184)		(3,846,085)		(2,199,556)

19

		$	(1,672,460)	$	(572,051)	$	(9,648,746)	$	(3,281,893)
Depreciation and amortization
	Construction Services	$	240,966	$	389,269	$	995,014	$	1,099,834
	Manufacturing		469,419		153,271		1,049,042		455,714
	Aerospace		222,291		-		448,659		-
	Defense		87,322		-		143,539		-
	Unallocated		158,807		10,520		215,715		27,056
		$	1,178,805	$	553,060	$	2,851,969	$	1,582,604
Interest Expense
	Construction Services	$	150,028	$	567,206	$	832,498	$	1,723,594
	Manufacturing		113,910		233,283		382,785		615,436
	Defense		-		-		825		-
	Unallocated		273,944		338,973		2,010,084		1,355,501
		$	537,882	$	1,139,462	$	3,226,192	$	3,694,531
Net income (loss)
	Construction Services	$	1,792,912	$	(1,027,073)	$	(881,293)	$	(1,240,693)
	Manufacturing		2,913,757		400,368		3,371,416		(1,145,527)
	Aerospace		(963,134)		-		(3,456,780)		-
	Defense		(120,481)		-		(114,097)		-
	Unallocated		(1,141,462)		(773,157)		(5,694,399)		(1,326,168)
		$	2,481,592	$	(1,399,862)	$	(6,775,153)	$	(3,712,388)

			As of September 30, 2021		As of December 31, 2020
Total Assets
	Construction Services	$	16,681,507	$	22,648,181
	Manufacturing		43,804,926		10,731,936
	Aerospace		14,332,809		6,342,863
	Defense		11,319,049		-
	Unallocated		10,973,041		1,011,203
		$	97,111,332	$	40,734,183
Goodwill
	Construction Services	$	121,221	$	121,221
	Manufacturing		2,216,612		1,963,761
	Defense		3,528,621		-
		$	5,866,454	$	2,084,982
Accounts receivable, net
	Construction Services	$	4,793,691	$	4,501,401
	Manufacturing		7,205,449		1,983,468
	Defense		991,089		-
		$	12,990,229	$	6,484,869

20

Note 11 – Commitments and Contingencies

Legal Proceedings

From time to time, the Company may become involved in lawsuits and other legal proceedings that arise in the course of business. Litigation is subject to inherent uncertainties, and it is not possible to predict the outcome of litigation with total confidence. As of the date of this Report, the Company was not aware of any legal proceedings or potential claims against it whose outcome would be likely, individually or in the aggregate, to have a material adverse effect on the Company’s business, financial condition, operating results, or cash flows, except as set forth below.

In June 2020, the Company’s subsidiary Excel Fabrication, LLC filed a lawsuit against Fusion Mechanical, LLC, in the Fifth Judicial District Court, State of Idaho (Case Number CV42-20-2246). The Company claimed tortious interference and trade secret violations by the defendant.  The defendant filed a motion to dismiss, which was denied by the Court. The defendant filed a second motion to dismiss and the Company filed a memorandum in response to the second motion to dismiss, for which a hearing was held on May 10, 2021. On June 11, 2021, the court issued a decision narrowing the claims of the plaintiffs to three items, breach of contract, good faith and fair dealings, and intentional interference for economic advantage. These were the Company’s three main points of contention. As of the date of this Report, discovery was proceeding. The Company intends to pursue vigorously its claims.

In August 2020, the Company filed a lawsuit, in the United States District Court, District of Arizona (Case No.2:20-cv-01679-DJH), against Alan Martin, the seller of Horizon Well Testing LLC (“HWT”) dba Venture West Energy Services, LLC. The Company brought claims for breach of contract, including but not limited to breaches of the seller’s representations and warranties in the purchase agreement in connection with the acquisition of HWT.  The defendant answered and counterclaimed, claiming breach by the Company of its obligation to issue a promissory note (to be issued in connection with the acquisition of HWT). The parties have engaged in discovery and settlement negotiations, both of which were ongoing as of the date of this Report. Additionally, a settlement conference is scheduled for November 18, 2021.

In May 2021, the Company and several shareholders filed a lawsuit, in the United States District Court for the District of Arizona (Case number 2:21-cv-00886-MTL) against Fin Capital LLC ("Fin Cap"), and Grizzly Research LLC ("Grizzly") alleging securities fraud, tortious interference with business expectancy and libel and slander for disseminating false and misleading statements about Alpine 4 and its employees to manipulate the stock price and further their own financial interests.

Note 12 – Subsequent Events

On November 1, 2021, the Company issued 2,506,249 shares of Class A common stock for no additional consideration upon conversion of 1,652,591 shares of Series C Preferred Stock and 1,432,244 shares of Series D Preferred Stock into Class A Common Stock, pursuant to the respective Certificates of Designation of the Series C and Series D Preferred Stock.

Identified Technologies Corporation

On October 20, 2021, the Company and the Company’s subsidiary, A4 Aerospace, Inc., a Delaware corporation (the “Buyer”), entered into a Stock Purchase Agreement (the “SPA”) with Identified Technologies Corporation, a Delaware corporation with foreign registration in Pennsylvania (the “Target”), and all of the shareholders of the Target: Birchmere Ventures 5 LP; Xalisco Ventures; Richard Zhang; Ashok Trivedi; Sunil Wadhwani; Innovation Works, Inc.; Startbot LLC; 2008 Mark Zappala IRR Trust; Birchmere Labs I LP; Cimax Partners I; Wu-Yang Family Trust; Zappala Family LP; and AT Gekko PR (each a “Shareholder” and collectively, the “Shareholders”).

Pursuant to the SPA, the Buyer purchased all of the outstanding shares of capital stock of the Target, a total of 6,486,044 shares of the Target’s capital stock (the “Target Shares”). The total purchase price for the Target Shares was $4,000,000 and was paid in shares of the Company’s Class A common stock (the “Company Shares”), issued to the Shareholders. Following the closing of the transaction, the Buyer owned 100% of the capital stock of the Target. The acquisition of the Target closed on October 20, 2021.

A total of 888,881 shares of restricted Class A common stock with a fair value of approximately $3.6 million were issued to the 13 Shareholders, together with an aggregate of $35.47 in cash (to avoid the issuance of fractional shares). Pursuant to the SPA, the Shareholders were limited to being able to sell 33% of their shares every 90 days once the Shares were no longer restricted pursuant to Rule 144.

21

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Management’s Discussion and Analysis of Financial Condition and Results of Operations is designed to provide a reader of the financial statements with a narrative report on our financial condition, results of operations, and liquidity. This discussion and analysis should be read in conjunction with the unaudited Financial Statements and notes thereto for the nine months ended September 30, 2021, included under Item 1 – Financial Statements in this Quarterly Report and our audited Financial Statements and notes thereto for the year ended December 31, 2020 contained in our Annual Report on Form 10-K. The following discussion contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations, and intentions. Our actual results could differ materially from those discussed in the forward-looking statements. Please also see the cautionary language at the beginning of this Quarterly Report regarding forward-looking statements.

Overview and Highlights

Company Background

Alpine 4 Holdings, Inc. (“we,” “our,” or the “Company”), was incorporated under the laws of the State of Delaware on April 22, 2014. We are a publicly traded conglomerate that is acquiring businesses that fit into its disruptive DSF business model of Drivers, Stabilizers, and Facilitators.   At Alpine 4, we understand the nature of how technology and innovation can accentuate a business.  Our focus is on how the adaptation of new technologies even in brick and mortar businesses can drive innovation.   We also believe that our holdings should benefit synergistically from each other and that the ability to have collaboration across varying industries can spawn new ideas and create fertile ground for competitive advantages.  This unique perspective has culminated in the development of our Blockchain-enabled Enterprise Business Operating System called SPECTRUMebos.

As of the date of this Report, the Company was a holding company that owned eleven operating subsidiaries:

-A4 Corporate Services, LLC;  

-ALTIA, LLC;  

-Quality Circuit Assembly, Inc.;  

-Morris Sheet Metal, Corp;  

-JTD Spiral, Inc.;  

-Excel Construction Services, LLC;  

-SPECTRUMebos, Inc.;  

- Vayu (US), Inc.; 

-Thermal Dynamics, Inc.;  

-Alternative Laboratories, LLC.; and 

-Identified Technologies Corporation. 

In the first quarter of 2020, we created three additional subsidiaries to act as silo holding companies, organized by industries. These silo subsidiaries are A4 Construction Services, Inc. (“A4 Construction”), A4 Manufacturing, Inc. (“A4 Manufacturing”), and A4 Technologies, Inc. (“A4 Technologies”). In the first quarter of 2021, we formed additional silo subsidiaries: A4 Defense Systems, Inc. (“A4 Defense”); and A4 Aerospace Corporation, Inc. (“A4 Aerospace”). All of these are Delaware corporations. Each is authorized to issue 1,500 shares of common stock with a par value of $0.01 per share, and the Company is the sole shareholder of each of these subsidiaries.  

In March 2021, the Company announced the combination of its subsidiaries Deluxe Sheet Metal, Inc. (Deluxe) and Morris Sheet Metal Corporation (Morris) to become one of the largest sheet metal contractors in the Midwest region of the United States. Both companies will be under the Morris Sheet Metal brand.  The Company’s management believes that the combination of these businesses will create a more harmonious relationship between the two companies. The combining of resources should empower Morris to strengthen its brand through its strategic banking relationship, eliminate duplicative and competitive interests, and expand its footprint beyond the Indiana home base.

On May 5, 2021, the Company acquired all of the outstanding shares of stock of Thermal Dynamics, Inc., a Delaware corporation (“Thermal Dynamics”).

On May 10, 2021, the Company acquired all of the outstanding membership interests of KAI Enterprises, LLC, a Florida limited liability company, the sole asset of which was all of the outstanding membership interests of Alternative Laboratories, LLC, a Delaware limited liability company (“Alt Labs”).

In June 2021, the Company announced the combination of its subsidiaries Impossible Aerospace (“IA”) and Vayu (US)  (“Vayu US”) to become Vayu Aerospace Corporation (“VAYU”).  The Company’s management believes that the combination of these businesses will create a more harmonious relationship between the two companies. The combining of resources should empower VAYU to strengthen its brand through its strategic banking relationship, eliminate duplicative and competitive interests, and expand its footprint beyond the Michigan home base.

22

On October 20, 2021, the Company acquired 100% of the outstanding shares of Identified Technologies Corporation, a Delaware corporation (“Identified Technologies”).

Alpine 4 maintains its corporate office at 2525 E. Arizona Biltmore Circle, Suite C237, Phoenix, Arizona 85016. ALTIA works out of the corporate office.  QCA rents a location at 1709 Junction Court #380 San Jose, California 95112. Deluxe Sheet Metal’s facilities are located at 6661 Lonewolf Dr, South Bend, Indiana 46628. Morris Sheet Metal and JTD Spiral are located at 6212 Highview Dr, Fort Wayne, Indiana 46818. Excel Construction Services’ office and fabrication space are located at 297 Wycoff Cir, Twin Falls, Idaho 83301. Impossible Aerospace’s headquarters are located at 2222 Ronald St, Santa Clara, California 95050. Vayu (US) has its headquarters at 3815 Plaza Drive, Ann Arbor, MI 48108. The headquarters for TDI are located at 14955 Technology Ct, Fort Myers, FL 33912. Alt Labs has its headquarters at 4070 S. Cleveland Ave. Fort Myers, FL 33907. The Identified Technologies Corporation headquarters are located at 6401 Penn Ave, Suite 211, Pittsburgh, PA 15206.

Business Strategy

What We Do:

Alexander Hamilton in his “Federalist paper #11”, said that our adventurous spirit distinguishes the commercial character of America.  Hamilton knew that our freedom to be creative gave American businesses a competitive advantage over the rest of the world.  We believe that Alpine 4 also exemplifies this spirit in our subsidiaries and that our greatest competitive advantage is our highly diverse business structure combined with a culture of collaboration.

It is our mandate to grow Alpine 4 into a leading, multi-faceted holding company with diverse subsidiary holdings with products and services that not only benefit from one another as a whole, but also have the benefit of independence.  This type of corporate structure is about having our subsidiaries prosper through strong onsite leadership while working synergistically with other Alpine 4 holdings.  The essence of our business model is based around acquiring B2B companies in a broad spectrum of industries via our acquisition strategy of DSF (Drivers, Stabilizer, Facilitator).  Our DSF business model (which is discussed more below) offers our shareholders an opportunity to own small-cap businesses that hold defensible positions in their individual market space.  Further, Alpine 4’s greatest opportunity for growth exists in the smaller to middle-market operating companies with revenues between $5 to $150 million annually.  In this target-rich environment, businesses generally sell at more reasonable multiples, presenting greater opportunities for operational and strategic improvements that have greater potential to enhance profit.

Driver, Stabilizer, Facilitator (DSF)

Driver:  A Driver is a company that is in an emerging market or technology, that has enormous upside potential for revenue and profits, with a significant market opportunity to access.  These types of acquisitions are typically small, brand new companies that need a structure to support their growth.

Stabilizer:  Stabilizers are companies that have sticky customers, consistent revenue and provide solid net profit returns to Alpine 4.

Facilitators:  Facilitators are our “secret sauce”.  Facilitators are companies that provide a product or service that an Alpine 4 sister company can use as leverage to create a competitive advantage.

When you blend these categories into a longer-term view of the business landscape, you can then begin to see the value-driving force that makes this a truly purposeful and powerful business model.  As stated earlier, our greatest competitive advantage is our highly diversified business structure combined with a collaborative business culture, that helps drive out competition in our markets by bringing; resources, planning, technology and capacity that our competitors simply do not have.  DSF reshapes the environment each subsidiary operates in by sharing and exploiting the resources each company has, thus giving them a competitive advantage that their peers do not have.

23

 

How We Do It:

Optimization vs. Asset Producing

The process to purchase a perspective company can be long and arduous.  During our due diligence period, we are validating and determining three major points, not just the historical record of the company we are buying.  Those three major points are what we call the “What is, What Should Be and What Will Be”.

•“The What Is” (TWI).  TWI is the defining point of where a company is holistically in a myriad of metrics; Sales, Finance, Ease of Operations, Ownership and Customer Relations to name a few. Subsequently, this is usually the point where most acquirers stop in their due diligence.  We look to define this position not just from a number’s standpoint, but also how does this perspective map out to a larger picture of culture and business environment. 

•“The What Should Be” (TWSB).  TWSB is the validation point of inflection where we use many data inputs to assess if TWI is out of the norm with competitors, and does that data show the potential for improvement. 

•“The What Will Be” (TWWB).  TWWB is how we seek to identify the net results or what we call Kinetic Profit (KP) between the TWI and TWSB.  The keywords are Kinetic Profit.  KP is the profit waiting to be achieved by some form of action or as we call it, the Optimization Phase of acquiring a new company. 

Optimization:  During the Optimization Phase, we seek to root up employees with in-depth training on various topics. Usually, these training sessions include; Profit and Expense Control, Production Planning, Breakeven Analysis and Profit Engineering to name a few.  But the end game is to guide these companies to: become net profitable with the new debt burden placed on them post-acquisition, mitigate the loss of sales due to acquisition attrition (we typically plan on 10% of our customers leaving simply due to old ownership not being involved in the company any longer), potential replacement of employees that No longer wish to be employed post-acquisition and other ancillary issues that may arise.  The Optimization Phase usually takes 12-18 months post-acquisition and a company can fall back into Optimization if it is stagnant or regresses in its training.

Asset Producing:  Asset Producing is the ideal point where we want our subsidiaries to be.  To become Asset Producing, subsidiary management must have completed prescribed training formats, proven they understand the key performance indicators that run their respective departments and finally, the subsidiaries they manage must have posted a net profit for 3 consecutive months.

24

Results of Operations

The following are the results of our operations for the three months ended September 30, 2021, as compared to the three months ended September 30, 2020.

			Three Months Ended September 30, 2021		Three Months Ended September 30, 2020		$ Change
Revenue		$	17,398,316	$	8,729,633	$	8,668,683
Cost of revenue			12,950,180		7,390,406		5,559,774
Gross Profit			4,448,136		1,339,227		3,108,909
Operating expenses:
	General and administrative expenses		5,539,465		1,911,278		3,628,187
	Research and development		581,131		-		581,131
	Total operating expenses		6,120,596		1,911,278		4,209,318
Loss from operations			(1,672,460)		(572,051)		(1,100,409)
Other income (expenses)
	Interest expense		(537,882)		(1,139,462)		601,580
	Gain (loss) on extinguishment of debt		-		253,063		(253,063)
	Gain on forgiveness of debt		4,307,291		-		4,307,291
	Bargain purchase gain		-		64,371		(64,371)
	Other income		438,701		(5,783)		444,484
	Total other income (expenses)		4,208,110		(827,811)		5,035,921
Income (loss) before income tax			2,535,650		(1,399,862)		3,935,512
Income tax expense			54,058		-		54,058
Net income (loss)		$	2,481,592	$	(1,399,862)	$	3,881,454

Revenue

Our revenues for the three months ended September 30, 2021, increased by $8,668,683 as compared to the three months ended September 30, 2020.  In 2021, the increase in revenue is related to the acquisition of TDI and Alt Labs. Revenue also increased due to additional jobs for QCA and Morris after the slowdown from COVID.

Cost of revenue

Our cost of revenue for the three months ended September 30, 2021, increased by $5,559,774 as compared to the three months ended September 30, 2020. In 2021, the increase in cost of revenue is related to the acquisition of TDI and Alt Labs. Cost of revenue also increased related to increased revenues for QCA and Morris. The net result of the increase in our cost of revenue dollars in comparison to our revenue was an increase in our gross profit percentage from 15.34% in the third quarter 2020 to 25.56% in the third quarter 2021.

Operating expenses

Our operating expenses for the three months ended September 30, 2021, increased by $4,209,318 as compared to the three months ended September 30, 2020. The increase is due to the acquisitions of TDI and Alt Labs. During 2021 the Company has been building its corporate infrastructure and adding additional executives and new staff in various areas, including accounting, software development, and engineering to handle future growth at the subsidiary level.

25

Other income (expenses)

Other income for the three months ended September 30, 2021, increased by $5,035,921 as compared to the same period in 2020. This increase was primarily due to forgiveness of the Paycheck Protection Program (“PPP”) Loans.

The following are the results of our operations for the nine months ended September 30, 2021, as compared to the nine months ended September 30, 2020.

			Nine Months Ended September 30, 2021		Nine Months Ended September 30, 2020		$ Change
Revenue		$	39,938,585	$	26,608,093	$	13,330,492
Cost of revenue			30,771,770		21,553,106		9,218,664
Gross Profit			9,166,815		5,054,987		4,111,828
Operating expenses:
	General and administrative expenses		17,719,228		7,225,280		10,493,948
	Impairment loss of intangible assets		-		1,111,600		(1,111,600)
	Research and development		1,096,333		-		1,096,333
	Total operating expenses		18,815,561		8,336,880		10,478,681
Loss from operations			(9,648,746)		(3,281,893)		(6,366,853)
Other income (expenses)
	Interest expense		(3,226,192)		(3,694,531)		468,339
	Change in value of derivative liability		-		2,298,609		(2,298,609)
	Gain on extinguishment of debt		803,079		344,704		458,375
	Change in fair value of contingent consideration		-		500,000		(500,000)
	Gain on forgiveness of debt		4,896,573		-		4,896,573
	Bargain purchase gain		-		64,371		(64,371)
	Other income		454,191		56,352		397,839
	Total other income (expenses)		2,927,651		(430,495)		3,358,146
Loss before income tax			(6,721,095)		(3,712,388)		(3,008,707)
Income tax expense			54,058		-		54,058
Net loss		$	(6,775,153)	$	(3,712,388)	$	(3,062,765)

During the nine months ended September 30, 2021, the Company had several one-time / non-recurring items included in the $6,775,153 net loss.  These non-recurring items totaled $3,613,435, consisting of $350,000 in new acquisitions expenses captured in professional fees, and other costs, $1,827,383 for repurchase of RSUs, and $1,436,052 in amortization for note discounts.

Revenue

Our revenues for the nine months ended September 30, 2021, increased by $13,330,492 as compared to the nine months ended September 30, 2020.  In 2021, the increase in revenue is related to the acquisition of TDI and Alt Labs. Revenue also increased due to additional jobs for QCA and Morris after the slowdown from COVID.  

Cost of revenue

Our cost of revenue for the nine months ended September 30, 2021, increased by $9,218,664 as compared to the nine months ended September 30, 2020. In 2021, the increase in cost of revenue is related to the acquisition of TDI and Alt Labs. Cost of revenue also increased related to increased revenues for QCA and Morris. The net result of the increase in our cost of revenue dollars in comparison to our revenue was an increase in our gross profit percentage from 18.99% in the first nine months of 2020 to 22.95% in the first nine months of 2021. 

26

Operating expenses

Our operating expenses for the nine months ended September 30, 2021, increased by $10,478,681 as compared to the nine months ended September 30, 2020.  The increase is due to the acquisitions of Vayu US, TDI, and Alt Labs; G&A expenses; and increased spending for infrastructure support at the corporate level of the Company. There were also one-time expenses for the repurchase of RSUs in connection with the acquisitions of Impossible Aerospace and Vayu of $1,100,451 and $726,932, respectively.

Other income (expenses)

Other income for the nine months ended September 30, 2021, increased by $3,358,146 as compared to the same period in 2020. This increase was primarily due to the forgiveness of PPP Loans.

Liquidity and Capital Resources

We have financed our operations since inception from existing revenue, the sale of common stock, capital contributions from stockholders and from the issuance of notes payable and convertible notes payable. We expect to continue to finance our operations from our current operating cash flow and by the selling shares of our common stock and or debt instruments. In the first quarter of 2021, we raised approximately $54,000,000 through the sale of our common stock.

In April and May 2020, we received seven loans under the Paycheck Protection Program of the U.S. Coronavirus Aid, Relief and Economic Security (“CARES”) Act totaling $3,896,107.  During the nine months ended September 30, 2021, the Company also acquired four loans totaling $1,799,725 due to acquisitions. The loans have terms of 24 months and accrue interest at 1% per annum. We expect some or all of these loans to be forgiven as provided by in the CARES Act. nine loans totaling $4,896,573 were forgiven during the nine months ended September 30, 2021.

Management expects to have sufficient working capital for continuing operations from either the sale of its products or through the raising of additional capital through private offerings of our securities and improved cash flows from operations including the two acquisitions that closed in May 2021. The Company also secured bank lines of credit totaling $9.3 million in 2021. Additionally, the Company is monitoring additional businesses to acquire which management hopes will provide additional operating revenues to the Company. There can be no guarantee that the planned acquisitions will close or that they will produce the anticipated revenues on the schedule anticipated by management.

The Company also may elect to seek additional bank financing, engage in debt financing through a placement agent, or sell shares of its common stock in public or private offering transactions. 

Off-Balance Sheet Arrangements

The Company has not entered into any transactions with unconsolidated entities whereby the Company has financial guarantees, subordinated retained interests, derivative instruments, or other contingent arrangements that expose the Company to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk, or credit risk support to the Company.

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable. In many instances, we could have reasonably used different accounting estimates and in other instances changes in the accounting estimates are reasonably likely to occur from period to period. This applies in particular to useful lives of non-current assets and valuation allowance for deferred tax assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. Management believes that there have been no changes in our critical accounting policies during the nine months ended September 30, 2021. 

For a summary of our critical accounting policies, refer to Note 2 of our consolidated financial statements included under Item 8 – Financial Statements in our Annual Report on Form 10-K filed on April 15, 2021.

27

Item 3. Quantitative and Qualitative Disclosures About Market Risk. 

As a Smaller Reporting Company, the Company is not required to include the disclosure under this Item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15 under the Securities Exchange Act of 1934, we have carried out an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report, September 30, 2021. This evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our company's reports filed under the Securities Exchange Act of 1934 is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.

Based upon that evaluation, we have concluded that our disclosure controls and procedures were ineffective as of the end of the period covered by this report due to the following material weaknesses in our internal control over financial reporting, many of which are indicative of many small companies with small staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) inadequate control activities and monitoring processes over financial reporting. However, as discussed in our Annual Report for the year ended December 31, 2020, we have hired additional qualified accounting personnel, including a Corporate Controller. We have continued to address and mitigate these material weaknesses through the implementation and testing of controls and ensure that controls that are properly designed are adequately performed to appropriately address risk related to critical functionality. Management will continue to work to improve the Company’s disclosure controls and procedures throughout 2021 and we believe that we have made significant progress in a short period of time. Management will continue to work to improve the Company’s disclosure controls and procedures throughout 2021, with a goal of remediating the material weaknesses no later than December 31, 2022. We believe that we have made significant progress.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2021, that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.

From time to time, the Company may become involved in lawsuits and other legal proceedings that arise in the course of business.  Litigation is subject to inherent uncertainties, and it is not possible to predict the outcome of litigation with total confidence. As of the date of this Report, the Company was not aware of any legal proceedings or potential claims against it whose outcome would be likely, individually or in the aggregate, to have a material adverse effect on the Company’s business, financial condition, operating results, or cash flows.

In June 2020, the Company’s subsidiary Excel Fabrication, LLC filed a lawsuit against Fusion Mechanical, LLC, in the Fifth Judicial District Court, State of Idaho (Case Number CV42-20-2246). The Company claimed tortious interference and trade secret violations by the defendant.  The defendant filed a motion to dismiss, which was denied by the Court. As of the date of this Report, discovery was proceeding. The defendant filed a second motion to dismiss and the Company filed a memorandum in response to the second motion to dismiss, for which a hearing was held on May 10, 2021. On June 11, 2021, the court issued a decision narrowing the claims of the plaintiffs to three items: breach of contract, good faith and fair dealings and intentional interference for economic advantage. These were the Company’s three main points of contention. As of the date of this Report, discovery was proceeding. The Company intends to pursue vigorously its claims.

In August 2020, the Company filed a lawsuit in the United States District Court, District of Arizona (Case No.2:20-cv-01679-DJH), against Alan Martin, the seller of Horizon Well Testing LLC (“HWT”) dba Venture West Energy Services, LLC. The Company brought claims for breach of contract, including but not limited to breaches of the seller’s representations and warranties in the purchase agreement in connection with the acquisition of HWT.  The defendant answered and counterclaimed, claiming breach by the Company of its obligation to issue a promissory note (to be issued in connection with the acquisition of HWT). The parties have engaged in discovery and settlement negotiations, both of which were ongoing as of the date of this Report. Additionally, a settlement conference is scheduled for November 18, 2021.

28

In May 2021, the Company and several shareholders filed a lawsuit in the United States District Court for the District of Arizona (Case number 2:21-cv-00886-MTL) against Fin Capital LLC ("Fin Cap"), and Grizzly Research LLC ("Grizzly") alleging securities fraud, tortious interference with business expectancy and libel slander for disseminating false and misleading statements about Alpine 4 and its employees to manipulate the stock price and further their own financial interests. As of the date of this Report, Fin Cap has not been served with the Complaint.  The Company plans to move for an order permitting public service of the Complaint on Fin Cap pursuant to Arizona law.

Item 1A.RISK FACTORS 

Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020, includes a detailed discussion of the Company’s risk factors. However, many of the risk factors disclosed in Item 1A of our Annual Report may be further heightened or exacerbated by the impact of the COVID-19 pandemic.

We continue to face risks related to Novel Coronavirus (COVID-19) which have significantly disrupted our manufacturing, research and development, operations, sales and financial results, and could continue to do so for the foreseeable future.

Our business has been and will continue to be adversely impacted by the effects of the Novel Coronavirus (“COVID-19”), although we are seeking to resume and rebuild operations of all of our subsidiaries to pre-COVID-19 levels.  Nevertheless, in addition to global macroeconomic effects, the COVID-19 outbreak and any other related adverse public health developments may continue to cause disruption to our international operations and sales activities. Our third-party manufacturers, suppliers, third-party distributors, sub-contractors and customers have been and will be disrupted by worker absenteeism, quarantines and restrictions on our employees’ ability to work, office and factory closures, disruptions to ports and other shipping infrastructure, border closures, or other travel or health-related restrictions. Depending on the magnitude of such effects on our manufacturing, assembling, and testing activities or the operations of our suppliers, third-party distributors, or sub-contractors, our supply chain, manufacturing and product shipments will be delayed, which could adversely affect our business, operations and customer relationships. In addition, COVID-19 and its variants or other disease outbreak will in the short-run and may over the longer term adversely affect the economies and financial markets of many countries, resulting in an economic downturn that will affect demand for our products and impact our operating results. There can be no assurance that any decrease in sales resulting from the COVID-19 outbreak will be offset by increased sales in subsequent periods. Although the magnitude of the impact of the COVID-19 outbreak on our business and operations remains uncertain, the continued spread of COVID-19 and any of its variants or the occurrence of other epidemics and the imposition of related public health measures and travel and business restrictions will adversely impact our business, financial condition, operating results and cash flows. In addition, we have experienced and will experience disruptions to our business operations resulting from quarantines, self-isolations, or other movement and restrictions on the ability of our employees to perform their jobs that may impact our ability to develop and design our products in a timely manner or meet required milestones or customer commitments.

The impact on our operations of shortages, or additional shortages that may surface, related to COVID-19 is uncertain, but could potentially impact our future sales, manufacturing operations and financial results.    Continued progression of these circumstances could result in a decline in customer orders, as our customers could shift purchases to lower-priced or other perceived value offerings or reduce their purchases and inventories due to decreased budgets, reduced access to credit or various other factors, and impair our ability to manufacture our products, which could have a material adverse impact on our results of operations and cash flow.  While the current impacts of COVID-19 are reflected in our results of operations, we cannot at this time separate the direct COVID-19 impacts from other factors that cause our performance to vary from quarter to quarter. The ultimate duration and impact of the COVID-19 pandemic on our business, results of operations, financial condition and cash flows is dependent on future developments, including the duration and severity of the pandemic, and the related length of its impact on the global economy, which are uncertain and cannot be predicted at this time. Even after the COVID-19 pandemic has subsided, we may continue to experience an adverse impact to our business as a result of its national and, to some extent, global economic impact. Furthermore, the extent to which our mitigation efforts are successful, if at all, is not presently ascertainable.  However, our results of operations in future periods may continue to be adversely impacted by the COVID-19 pandemic and its negative effects on global economic conditions.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.

Issuances in 2021

In January 2021, the Company issued 1,432,244 shares of Series D Preferred Stock in connection with the Vayu (US) merger transaction.

The shares of Series D Preferred Stock issued in connection with the Vayu (US) merger transaction were issued without registration under the 1933 Act in reliance on Section 4(a)(2) of the 1933 Act and the rules and regulations promulgated thereunder.

In the nine-months ended September 30, 2021, the Company issued an aggregate of 7,384,018 shares of its restricted Class A common stock for convertible debt of $1,886,898 from 2020.

29

The shares of Class A common stock referenced above that were issued in 2021, were issued without registration under the 1933 Act in reliance on Section 4(a)(2) of the 1933 Act and the rules and regulations promulgated thereunder.

In May 2021, the Company issued 281,223 shares of Class A common stock in connection with the TDI acquisition.

The shares of Class A common stock issued in connection with the TDI acquisition were issued without registration under the 1933 Act in reliance on Section 4(a)(2) of the 1933 Act and the rules and regulations promulgated thereunder.

In May 2021, the Company issued 361,787 shares of Class A common stock in connection with the Alt Labs acquisition.

The shares of Class A common stock issued in connection with the Alt Labs acquisition were issued were issued without registration under the 1933 Act in reliance on Section 4(a)(2) of the 1933 Act and the rules and regulations promulgated thereunder.

On April 30, 2021, the Company issued 1,617,067 shares of Class A common stock upon conversion of shares of Class C common stock by the holder of the Class C common stock.

The shares of Class A common stock issued upon conversion of the Class C common stock into Class A common stock were issued without registration under the 1933 Act in reliance on Section 4(a)(2) of the 1933 Act and the rules and regulations promulgated thereunder.

On May 17, 2021, the Company issued 350,000 shares of Class A common stock upon conversion of shares of Class B common stock by the holder of the Class B common stock.

The shares of Class A common stock issued upon conversion of the Class B common stock were issued without registration under the 1933 Act in reliance on Section 4(a)(2) of the 1933 Act and the rules and regulations promulgated thereunder.

On October 20, 2021, in connection with the purchase of the outstanding securities of Identified Technologies Corporation, the Company issued 888,881 shares of its Class A Common Stock.

The shares of Class A common stock issued in connection with the Identified Technologies Corporation acquisition were issued were issued without registration under the 1933 Act in reliance on Section 4(a)(2) of the 1933 Act and the rules and regulations promulgated thereunder.

On November 1, 2021, the Company issued 2,506,249 shares of Class A common stock for no additional consideration upon conversion of 1,652,591 shares of Series D Preferred Stock and 1,432,244 shares of Series C Preferred Stock.

The shares of Class A common stock issued upon conversion of the Series C and Series D Preferred Stock into Class A common stock were issued without registration under the 1933 Act in reliance on Section 4(a)(2) of the 1933 Act and the rules and regulations promulgated thereunder.

Item 3.  Defaults Upon Senior Securities.

None

Item 5.  Other Information

Not Applicable

Item 6.  Exhibits.

Exhibit Number	Description
2.1	Impossible Aerospace Merger Agreement dated November 13, 2020 (incorporated by reference to Exhibit 3.4 to Alpine 4’s Current Report on Form 8-K filed November 17, 2020).
2.2	Vayu (US) Merger Agreement dated December 29, 2020 (incorporated by reference to Exhibit 3.4 to Alpine 4’s Current Report on Form 8-K filed January 4, 2021).
3.1	Series C Preferred Stock Certificate of Designation (incorporated by reference to Exhibit 3.4 to Alpine 4’s Current Report on Form 8-K filed November 17, 2020).
3.2	Series D Preferred Stock Certificate of Designation (incorporated by reference to Exhibit 3.4 to Alpine 4’s Current Report on Form 8-K filed January 4, 2021).

30

3.3	Certificate of Amendment to Certificate of Incorporation (Name Change) filed February 5, 2021 (incorporated by reference to Exhibit 3.4 to Alpine 4’s Current Report on Form 8-K filed February 8, 2021).
10.1	Impossible Aerospace Consultant Agreement dated November 13, 2020 (incorporated by reference to Exhibit 10.1 to Alpine 4’s Current Report on Form 8-K filed November 17, 2020).
10.2	RSU Agreement dated November 13, 2020 (incorporated by reference to Exhibit 10.2 to Alpine 4’s Current Report on Form 8-K filed November 17, 2020).
10.3	Vayu (US) Employment Agreement dated December 29, 2020 (incorporated by reference to Exhibit 10.1 to Alpine 4’s Current Report on Form 8-K filed January 4, 2021).
10.4	RSU Agreement dated December 29, 2020 (incorporated by reference to Exhibit 10.2 to Alpine 4’s Current Report on Form 8-K filed January 4, 2021).
10.5	Form of Securities Purchase Agreement (AGP Transaction) (incorporated by reference to Exhibit 10.1 to Alpine 4’s Current Report on Form 8-K filed February 12, 2021).
10.6	Form of Placement Agent Agreement (incorporated by reference to Exhibit 10.2 to Alpine 4’s Current Report on Form 8-K filed February 12, 2021).
10.7	Stock Purchase Agreement by and among A4 Defense Services, Inc., Thermal Dynamics International, Inc., Page Management Co., Inc., and Stephen L. Page (previously filed as Exhibit 10.1 to the Company’s Current Report filed on May 4, 2021, and incorporated herein by reference).
10.8	Membership Interest Purchase Agreement by and among A4 Manufacturing, Inc., Alpine 4 Holdings, Inc., Alternative Laboratories, LLC, KAI Enterprises, LLC, and Kevin Thomas (previously filed as Exhibit 10.1 to the Company’s Current Report filed on May 10, 2021, and incorporated herein by reference).
10.9	Commercial Lease Agreement by and between 4740 Cleveland, LLC, and Alternative Laboratories, LLC (previously filed as Exhibit 10.4 to the Company’s Current Report filed on May 10, 2021, and incorporated herein by reference).
10.10	Membership Interest Purchase Agreement by and among A4 Manufacturing, Inc., Alpine 4 Holdings, Inc., 4740 Cleveland, LLC, and Kevin Thomas (previously filed as Exhibit 10.5 to the Company’s Current Report filed on May 10, 2021, and incorporated herein by reference).
10.11	Identified Technologies Corporation Stock Purchase Agreement, dated October 20, 2021 (previously filed as Exhibit 10 to the Company’s Current Report filed on October 25, 2021, and incorporated herein by reference).
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Accounting Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101 INS	XBRL Instance Document*
101 SCH	XBRL Schema Document*
101 CAL	XBRL Calculation Linkbase Document*
101 DEF	XBRL Definition Linkbase Document*
101 LAB	XBRL Labels Linkbase Document*
101 PRE	XBRL Presentation Linkbase Document*

*The XBRL related information in Exhibit 101 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

31

SIGNATURES

In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Alpine 4 Holdings, Inc.
Dated: November 4, 2021
	By:	/s/ Kent B. Wilson
		Kent B. Wilson
		Chief Executive Officer
		(Principal Executive Officer)
	By:	/s/ Larry Zic
		Larry Zic
		Chief Financial Officer
		(Principal Financial Officer)

32

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Kent B. Wilson, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Alpine 4 Holdings, Inc. (formerly Alpine 4 Technologies Ltd.); 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

Dated:  November 4, 2021

By: /s/ Kent B. Wilson  

Kent B. Wilson

Chief Executive Officer

(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Larry Zic, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Alpine 4 Holdings, Inc. (formerly Alpine 4 Technologies Ltd.); 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

Dated:  November 4, 2021

By: /s/ Larry Zic  

Larry Zic

Chief Financial Officer

(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-K of Alpine 4 Holdings, Inc. (formerly Alpine 4 Technologies Ltd.) (the “Company”) for the quarter ending September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Kent B. Wilson, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

Dated:  November 4, 2021	By: /s/	Kent B. Wilson
		Kent B. Wilson
		Chief Executive Officer

This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-K of Alpine 4 Holdings, Inc. (formerly Alpine 4 Technologies Ltd.) (the “Company”) for the quarter ending September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Larry Zic, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

Dated:  November 4, 2021	By: /s/	Larry Zic
		Larry Zic
		Chief Financial Officer

This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 01, 2021
Registrant CIK	0001606698
Fiscal Year End	--12-31
Registrant Name	Alpine 4 Holdings, Inc.
SEC Form	10-Q
Period End date	Sep. 30, 2021
Tax Identification Number (TIN)	46-5482689
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Shell Company	false
Small Business	true
Emerging Growth Company	true
Ex Transition Period	true
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-55205
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2525 E Arizona Biltmore Circle
Entity Address, Address Line Two	Suite 237
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85016
City Area Code	480
Local Phone Number	702-2431
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Common Class A
Number of common stock shares outstanding		149,609,780
Common Class B
Number of common stock shares outstanding		8,673,088
Common Class C
Number of common stock shares outstanding		12,500,200

XML

Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash	$ 5,425,913	$ 277,738
Restricted Cash	0	444,845
Accounts receivable, net	12,990,229	6,484,869
Contract assets	3,655,625	717,421
Inventory, net	9,632,121	2,666,602
Prepaid expenses and other current assets	1,272,760	32,301
Total current assets	32,976,648	10,623,776
Investment in equity securities	1,350,000	0
Property and equipment, net	27,320,596	19,299,286
Intangible asset, net	29,001,665	7,743,084
Right of use assets, net	347,712	581,311
Goodwill	5,866,454	2,084,982
Other non-current assets	248,257	401,744
TOTAL ASSETS	97,111,332	40,734,183
CURRENT LIABILITIES:
Accounts payable	5,653,158	4,854,467
Accrued expenses	4,253,987	2,872,202
Contract liabilities	3,486,331	233,485
Line of credit	3,718,972	0
Notes payable, current portion	5,811,241	7,100,911
Notes payable, related parties	3,000	238,651
Convertible notes payable, current	7,500	562,242
Financing lease obligation, current portion	628,574	639,527
Operating lease obligation, current portion	135,207	334,500
Total current liabilities	23,697,970	16,835,985
Notes payable, net of current portion	7,522,462	15,201,450
Convertible notes payable, net of current portion	0	1,100,635
Financing lease obligations, net of current portion	15,489,693	15,687,176
Operating lease obligations, net of current portion	219,682	269,030
Deferred tax liability	428,199	428,199
TOTAL LIABILITIES	47,358,006	49,522,475
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	0	0
Additional paid-in capital	96,306,820	30,991,978
Accumulated deficit	(46,570,554)	(39,795,401)
Total stockholders' equity (deficit)	49,753,326	(8,788,292)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	97,111,332	40,734,183
Series B Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	5	5
Total stockholders' equity (deficit)	5	5
Series C Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	171	171
Total stockholders' equity (deficit)	171	171
Series D Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	143	0
Total stockholders' equity (deficit)	143	0
Common Class A
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	14,624	12,636
Total stockholders' equity (deficit)	14,624	12,636
Common Class B
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	867	902
Total stockholders' equity (deficit)	867	902
Common Class C
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	1,250	1,417
Total stockholders' equity (deficit)	$ 1,250	$ 1,417

XML

Consolidated Balance Sheets - Parenthetical - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Series B Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 1.00	$ 1.00
Preferred Stock, Shares Authorized	100	100
Preferred Stock, Shares Issued	5	5
Preferred Stock, Shares Outstanding	5	5
Series C Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 3.50	$ 3.50
Preferred Stock, Shares Authorized	2,028,572	2,028,572
Preferred Stock, Shares Issued	1,714,286	1,714,286
Preferred Stock, Shares Outstanding	1,714,286	1,714,286
Series D Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 3.50	$ 3.50
Preferred Stock, Shares Authorized	1,628,572	1,628,572
Preferred Stock, Shares Issued	1,432,244	0
Preferred Stock, Shares Outstanding	1,432,244	0
Common Class A
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	195,000,000	195,000,000
Common Stock, Shares, Issued	146,214,650	126,363,158
Common Stock, Shares, Outstanding	146,214,650	126,363,158
Common Class B
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	10,000,000	10,000,000
Common Stock, Shares, Issued	8,673,088	9,023,088
Common Stock, Shares, Outstanding	8,673,088	9,023,088
Common Class C
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	15,000,000	15,000,000
Common Stock, Shares, Issued	12,500,200	14,162,267
Common Stock, Shares, Outstanding	12,500,200	14,162,267

XML

Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Revenue	$ 17,398,316	$ 8,729,633	$ 39,938,585	$ 26,608,093
Cost of revenue	12,950,180	7,390,406	30,771,770	21,553,106
Gross Profit	4,448,136	1,339,227	9,166,815	5,054,987
Operating expenses:
General and administrative expenses	5,539,465	1,911,278	17,719,228	7,225,280
Impairment loss of intangible assets and goodwill	0	0	0	1,111,600
Research and development	581,131	0	1,096,333	0
Total operating expenses	6,120,596	1,911,278	18,815,561	8,336,880
Loss from operations	(1,672,460)	(572,051)	(9,648,746)	(3,281,893)
Other income (expenses)
Interest expense	(537,882)	(1,139,462)	(3,226,192)	(3,694,531)
Change in value of derivative liability	0	0	0	2,298,609
Gain (loss) on extinguishment of debt	0	253,063	803,079	344,704
Gain on forgiveness of debt	4,307,291	0	4,896,573	0
Bargain purchase gain	0	64,371	0	64,371
Change in fair value of contingent consideration	0	0	0	500,000
Other income	438,701	(5,783)	454,191	56,352
Total other income (expenses)	4,208,110	(827,811)	2,927,651	(430,495)
Income (loss) before income tax	2,535,650	(1,399,862)	(6,721,095)	(3,712,388)
Income tax	54,058	0	54,058	0
Net income (loss)	$ 2,481,592	$ (1,399,862)	$ (6,775,153)	$ (3,712,388)
Weighted average shares outstanding:
Weighted Average Number of Shares Outstanding, Basic	166,964,408	131,934,084	161,118,324	130,111,673
Weighted Average Number of Shares Outstanding, Diluted	168,627,907	131,934,084	161,118,324	138,238,550
Earnings Per Share, Basic	$ 0.01	$ (0.01)	$ (0.04)	$ (0.03)
Earnings Per Share, Diluted	$ 0.01	$ (0.01)	$ (0.04)	$ (0.04)

XML

Consolidated Statements Changes in Stockholders' Equity (Deficit) - USD ($)	Additional Paid-in Capital	Retained Earnings	Total	Series B Preferred Stock	Series C Preferred Stock	Series D Preferred Stock	Common Class A	Common Class B	Common Class C
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2019	$ 19,763,883	$ (31,745,528)	$ (11,970,142)	$ 0	$ 0	$ 0	$ 10,007	$ 500	$ 996
Shares, Outstanding, Beginning Balance at Dec. 31, 2019				0	0	0	100,070,161	5,000,000	9,955,200
Stock Issued During Period, Value, New Issues	249,606	0	250,000	$ 0	$ 0	$ 0	$ 394	$ 0	$ 0
Stock Issued During Period, Shares, New Issues							3,941,753
Issuance of shares of common stock for modification of debt	330,204	0	330,528	$ 0	0	0	$ 162	0	$ 162
Issuance of shares of common stock for modification of debt, shares				0			1,617,067		1,617,067
Issuance Of Shares Of Common Stock For Penalty	44,670	0	44,700	$ 0	0	0	$ 30	0	$ 0
Issuance Of Shares Of Common Stock For Penalty, Shares				0			300,000
Issuance of shares of common stock for convertible note payable and accrued interest	696,868	0	697,332	$ 0	0	0	$ 464	0	0
Issuance of shares of common stock for convertible note payable and accrued interest, shares				0			4,648,879
Issuance Of Shares Of Common Stock For Compensation, Value	603,061	0	603,463	$ 0	0	0	$ 0	$ 402	0
Issuance Of Shares Of Common Stock For Compensation, Shares								4,023,088
Issuance Of Shares Of Series B Preferred Stock, Value	0	0	5	$ 5	0	0	0	$ 0	0
Issuance Of Shares Of Series B Preferred Stock, Shares				5
Share-based compensation expense	19,556	0	19,556	$ 0	0	0	0	0	0
Net income (loss)	0	250,388	250,388	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2020	21,707,848	(31,495,140)	(9,774,170)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Mar. 31, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2019	19,763,883	(31,745,528)	(11,970,142)	$ 0	$ 0	$ 0	$ 10,007	$ 500	$ 996
Shares, Outstanding, Beginning Balance at Dec. 31, 2019				0	0	0	100,070,161	5,000,000	9,955,200
Net income (loss)			(3,712,388)
Stockholders' Equity Attributable to Parent, Ending Balance at Sep. 30, 2020	21,870,874	(35,457,916)	(13,573,620)	$ 5	$ 0	$ 0	$ 11,357	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Sep. 30, 2020				5	0	0	113,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Mar. 31, 2020	21,707,848	(31,495,140)	(9,774,170)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Beginning Balance at Mar. 31, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Share-based compensation expense	19,556	0	19,556	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Net income (loss)	0	(2,562,914)	(2,562,914)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2020	21,727,404	(34,058,054)	(12,317,528)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Jun. 30, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Stock Issued During Period, Value, New Issues	123,700	0	124,000	$ 0	$ 0	$ 0	$ 300	$ 0	$ 0
Stock Issued During Period, Shares, New Issues							3,000,000
Share-based compensation expense	19,770	0	19,770	0	0	0	$ 0	0	0
Net income (loss)	0	(1,399,862)	(1,399,862)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Sep. 30, 2020	21,870,874	(35,457,916)	(13,573,620)	$ 5	$ 0	$ 0	$ 11,357	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Sep. 30, 2020				5	0	0	113,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	30,991,978	(39,795,401)	(8,788,292)	$ 5	$ 171	$ 0	$ 12,636	$ 902	$ 1,417
Shares, Outstanding, Beginning Balance at Dec. 31, 2020				5	1,714,286	0	126,363,158	9,023,088	14,162,267
Issuance Of Shares Of Common Stock For Cash, Net Of Offering Costs, Value	54,301,997	0	54,302,982	$ 0	$ 0	$ 0	$ 985	$ 0	$ 0
Issuance Of Shares Of Common Stock For Cash, Net Of Offering Costs, Shares							9,857,397
Issuance of shares of common stock for convertible note payable and accrued interest	109,760	0	109,830	0	0	0	$ 70	0	0
Issuance of shares of common stock for convertible note payable and accrued interest, shares							702,877
Stock Issued During Period, Value, Acquisitions	6,653,166	0	6,653,309	0	0	$ 143	$ 0	0	0
Stock Issued During Period, Shares, Acquisitions						1,432,244
Repurchase Of Class C Common Stock, Value	(185,845)	0	(185,850)	0	0	$ 0	0	0	(5)
Share-based compensation expense	19,341	0	19,341	0	0	0	0	0	0
Beneficial conversion feature on convertible notes	92,428	0	92,428	0	0	0	0	0	0
Net income (loss)	0	(6,129,468)	(6,129,468)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2021	91,982,825	(45,924,869)	46,074,280	$ 5	$ 171	$ 143	$ 13,691	$ 902	$ 1,412
Shares, Outstanding, Ending Balance at Mar. 31, 2021				5	1,714,286	1,432,244	136,923,432	9,023,088	14,117,267
Repurchase Of Class C Common Stock, Shares									(45,000)
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	30,991,978	(39,795,401)	(8,788,292)	$ 5	$ 171	$ 0	$ 12,636	$ 902	$ 1,417
Shares, Outstanding, Beginning Balance at Dec. 31, 2020				5	1,714,286	0	126,363,158	9,023,088	14,162,267
Net income (loss)			(6,775,153)
Stockholders' Equity Attributable to Parent, Ending Balance at Sep. 30, 2021	96,306,820	(46,570,554)	49,753,326	$ 5	$ 171	$ 143	$ 14,624	$ 867	$ 1,250
Shares, Outstanding, Ending Balance at Sep. 30, 2021				5	1,714,286	1,432,244	146,214,650	8,673,088	12,500,200
Stockholders' Equity Attributable to Parent, Beginning Balance at Mar. 31, 2021	91,982,825	(45,924,869)	46,074,280	$ 5	$ 171	$ 143	$ 13,691	$ 902	$ 1,412
Shares, Outstanding, Beginning Balance at Mar. 31, 2021				5	1,714,286	1,432,244	136,923,432	9,023,088	14,117,267
Issuance of shares of common stock for convertible note payable and accrued interest	1,419,034	0	1,419,568	$ 0	$ 0	$ 0	$ 534	$ 0	$ 0
Issuance of shares of common stock for convertible note payable and accrued interest, shares							5,295,308
Stock Issued During Period, Value, Acquisitions	2,535,007	0	2,535,071	0	0	0	$ 64	0	0
Stock Issued During Period, Shares, Acquisitions							643,010
Conversion of Class C to Class A, Value	0	0	0	0	0	0	$ 162	0	$ (162)
Conversion of Class C to Class A, Shares							1,617,067		(1,617,067)
Conversion of Class B to Class A, Value	0	0	0	0	0	0	$ 35	$ (35)	$ 0
Conversion of Class B to Class A, Shares							350,000	(350,000)
Share-based compensation expense	7,988	0	7,988	0	0	0	$ 0	$ 0	0
Net income (loss)	0	(3,127,277)	(3,127,277)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2021	95,944,854	(49,052,146)	46,909,630	$ 5	$ 171	$ 143	$ 14,486	$ 867	$ 1,250
Shares, Outstanding, Ending Balance at Jun. 30, 2021				5	1,714,286	1,432,244	144,828,817	8,673,088	12,500,200
Issuance of shares of common stock for convertible note payable and accrued interest	357,362	0	357,500	$ 0	$ 0	$ 0	$ 138	$ 0	$ 0
Issuance of shares of common stock for convertible note payable and accrued interest, shares							1,385,833
Conversion of Class C to Class A, Shares							1,617,067		(1,617,067)
Conversion of Class B to Class A, Shares							350,000	(350,000)
Share-based compensation expense	4,604	0	4,604	0	0	0	$ 0	$ 0	$ 0
Net income (loss)	0	2,481,592	2,481,592	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Sep. 30, 2021	$ 96,306,820	$ (46,570,554)	$ 49,753,326	$ 5	$ 171	$ 143	$ 14,624	$ 867	$ 1,250
Shares, Outstanding, Ending Balance at Sep. 30, 2021				5	1,714,286	1,432,244	146,214,650	8,673,088	12,500,200

XML

Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Net Cash Provided by (Used in) Operating Activities
Net income (loss)	$ (6,775,153)	$ (3,712,388)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,851,969	1,582,604
Gain on extinguishment of debt	(803,079)	(344,704)
Gain of forgiveness of debt	(4,896,573)	0
Change in fair value of contingent consideration	0	(500,000)
Change in fair value of derivative liabilities	0	(2,298,609)
Stock issued for penalties	0	44,700
Employee stock compensation	31,933	58,887
Amortization of debt discounts	1,436,052	507,534
Non-cash lease expense	328,628	200,165
Bargain purchase gain	0	(64,371)
Impairment loss of intangible asset and goodwill	0	1,111,600
Write off of inventory	0	127,919
Change in current assets and liabilities:
Increase (Decrease) in Receivables	(6,096,678)	2,542,306
Increase (Decrease) in Inventories	(4,343,866)	(146,925)
Capitalized Contract Cost, Amortization	(2,111,973)	158,978
Increase (Decrease) in Prepaid Expense	(696,471)	141,147
Increase (Decrease) in Accounts Payable	(17,460)	(661,933)
Increase (Decrease) in Accrued Liabilities	1,045,007	159,828
Increase (Decrease) in Contract with Customer, Liability	(835,632)	(71,548)
Operating lease liability	(343,670)	(189,503)
Increase (Decrease) in Deferred Revenue	0	(12,509)
Net cash used in operating activities	(21,226,966)	(1,366,822)
Net Cash Provided by (Used in) Investing Activities
Capital expenditures	(2,970,087)	(75,670)
Cash paid for equity investment	(350,000)	0
Cash paid for acquisitions	(16,824,000)	(2,513,355)
Cash assumed in acquisition	81,442	0
Net cash used in investing activities	(20,062,645)	(2,589,025)
Net Cash Provided by (Used in) Financing Activities
Proceeds from the sale of common stock, net of offering costs	54,302,982	374,000
Proceeds from issuances of notes payable, related parties	0	47,000
Proceeds from issuances of notes payable, non-related party	15,609	4,644,817
Proceeds from issuances of convertible notes payable	408,000	0
Proceeds from line of credit	3,718,972	0
Proceeds from financing lease	0	2,000,000
Repurchase of common stock	(185,850)	0
Repayments of notes payable, related party	(235,651)	(217,822)
Repayments of notes payable, non-related parties	(7,041,401)	(1,745,647)
Repayments of convertible notes payable	(1,680,964)	(270,294)
Repayment of line of credit	(2,821,033)	(660,764)
Cash paid on financing lease obligations	(487,723)	(355,094)
Net cash provided by financing activities	45,992,941	3,816,196
NET INCREASE (DECREASE) IN CASH AND RESTRICTED CASH	4,703,330	(139,651)
CASH AND RESTRICTED CASH, BEGINNING BALANCE	722,583	302,486
CASH AND RESTRICTED CASH, ENDING BALANCE	5,425,913	162,835
Supplemental Cash Flow Information
Interest Paid	1,593,255	2,857,895
Income Taxes Paid	54,058	0
Supplemental Cash Flow Elements
Penalty interest added to debt	0	15,000
Common stock issued for convertible note payable and accrued interest	1,886,898	697,332
Common stock issued for debt settlement	0	330,528
Issuance of note payable for acquisition	0	2,300,000
Common stock issued for acquisition	2,535,071	0
Common stock issued to settle unpaid salaries	0	603,463
ROU asset and operating lease obligation recognized under Topic 842	95,029	193,541
Remeasurement of finance lease liability	279,287	0
Equipment purchased on financing lease	0	756,990
Mortgage on property purchase	4,680,000	0
Accounts receivable converted to equity investment	1,000,000	0
Other asset reclassified to fixed asset	0	86,471
Issuance of shares of series D preferred stock for acquisition	6,653,309	0
Interest added to note payable - related party	0	134,185
Beneficial conversion feature on convertible notes	$ 92,428	$ 0

XML

Note 1 - Organization and Basis of Presentation

9 Months Ended

Sep. 30, 2021

Notes

Note 1 - Organization and Basis of Presentation

Note 1 – Organization and Basis of Presentation

The unaudited consolidated financial statements were prepared by Alpine 4 Holdings, Inc. (‘we,” “our,” or the "Company"), pursuant to the rules and regulations of the Securities Exchange Commission ("SEC"). The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") were omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company's Annual Report on Form 10-K filed with the SEC on April 15, 2021. The results for the nine months ended September 30, 2021, are not necessarily indicative of the results to be expected for the year ending December 31, 2021.

The Company was incorporated under the laws of the State of Delaware on April 22, 2014.  The Company was formed to serve as a vehicle to affect an asset acquisition, merger, exchange of capital stock, or other business combination with a domestic or foreign business.  On March 2, 2021, the Company changed its name from Alpine 4 Technologies Ltd. to Alpine 4 Holdings, Inc.

Effective April 1, 2016, the Company purchased all of the outstanding capital stock of Quality Circuit Assembly, Inc., a California corporation (“QCA”).

Effective January 1, 2019, the Company purchased all of the outstanding capital stock or equity interests in Morris Sheet Metal Corp., an Indiana corporation (“MSM”); JTD Spiral, Inc., an Indiana corporation wholly owned by MSM; Morris Enterprises LLC, an Indiana limited liability company; and Morris Transportation LLC, an Indiana limited liability company (collectively “Morris”).

Effective November 6, 2019, the Company purchased all of the outstanding capital stock and units of Deluxe Sheet Metal, Inc., an Indiana corporation, and DSM Holding, LLC, an Indiana limited liability company; and purchased certain real estate from Lonewolf Enterprises, LLC, an Indiana limited liability company (collectively “Deluxe”).

Effective February 21, 2020, the Company purchased all of the outstanding units of Excel Fabrication, LLC., an Idaho limited liability company (“Excel”).  Excel subsequently changed its name to Excel Construction Services, LLC.

Effective December 15, 2020, the Company purchased the assets of Impossible Aerospace Corporation, a Delaware corporation (“IA”).

Effective February 8, 2021, the Company purchased the assets of Vayu (US), Inc., a Delaware corporation (“Vayu”).

On May 5, 2021, the Company acquired all of the outstanding shares of stock of Thermal Dynamics, Inc., a Delaware corporation (“TDI”).

On May 10, 2021, the Company acquired all of the outstanding membership interests of KAI Enterprises, LLC, a Florida limited liability company, the sole asset of which was all of the outstanding membership interests of Alternative Laboratories, LLC, a Delaware limited liability company (“Alt Labs”).

On October 20, 2021, after the period covered by this Report, the Company acquired 100% of the outstanding shares of Identified Technologies Corporation, a Delaware corporation (“Identified Technologies”).

As of the date of this Report, the Company was a holding company owning, directly or indirectly, eleven companies:

·A4 Corporate Services, LLC;  

·ALTIA, LLC;  

·Quality Circuit Assembly, Inc.;  

·Morris Sheet Metal, Corp;  

·JTD Spiral, Inc.;  

·Excel Construction Services, LLC;  

·SPECTRUMebos, Inc.;  

·Vayu (US); 

·Thermal Dynamics, Inc.; 

·Alternative Laboratories, LLC.; and 

·Identified Technologies Corporation. 

Basis of presentation

The accompanying consolidated financial statements present the balance sheets, statements of operations, stockholders' deficit and cash flows of the Company. The financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”).

Liquidity

The Company’s financial statements are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued.

In accordance with Financial Accounting Standards Board (the “FASB”), Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

While the Company experienced a loss for the nine months ended September 30, 2021, of $6.8 million, and had a negative cash flow used in operations, there were several significant one-time / non-recurring items included in the $6.8 million net loss.  These non-recurring items totaled $2.2 million, consisting of $350 thousand in new acquisitions expenses captured in professional fees, and other costs, and $1.8 million for repurchase of RSUs.

The Company received a total of approximately $54.0 million in February 2021 in the following two transactions:

·The Company raised approximately $45.0 million in net proceeds in connection with a registered direct offering of its stock and;  

·The Company raised approximately $9.0 million in net proceeds in connection with an equity line of credit financing arrangement.  

The Company has secured bank financing totaling $9.3 million ($8.3 million in Lines of Credit and $1.0 million in capital expenditures lines of credit availability) of which $5.6 million was unused at September 30, 2021.

The Company plans to continue to generate additional revenue (and improve cash flows from operations) partly from the acquisitions of three operating companies which closed in May 2021 and October 2021 combined with improved gross profit performance from the existing operating companies.

Based on the capital raise as indicated above and management’s plans to improve cash flows from operations, management believes the Company has sufficient working capital to satisfy the Company’s estimated liquidity needs for the next 12 months. The Company ended the September 30, 2021, quarter with approximately $5.4 million in cash and working capital of $9.3 million. As of the date of this Report, the Company had approximately $3.5 million in cash. During the nine months ended September 30, 2021, the Company paid down liabilities of approximately $13.1 million. In addition, approximately $7.2 million was used to build inventory and for capital expenditures.

However, there is no assurance that management’s plans will be successful due to the current economic climate in the United States and globally.

XML

Note 2 - Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2021

Notes

Note 2 - Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

Principles of consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of September 30, 2021 and December 31, 2020.  Significant intercompany balances and transactions have been eliminated.

Use of estimates

The consolidated financial statements are prepared in accordance with U.S. GAAP.  Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. In many instances, the Company could have reasonably used different accounting estimates and in other instances changes in the accounting estimates are reasonably likely to occur from period to period. This applies in particular to useful lives of long-lived assets, valuation allowance for deferred tax assets and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial

statement presentation, financial condition, results of operations and cash flows will be affected.  The ultimate impact from COVID-19 on the Company’s operations and financial results during 2021 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, and the speed with which the economy recovers. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during 2021 and beyond.  COVID-19 did have a negative impact on the Company’s financial performance in 2020.  During the nine months ended September 30, 2021, there was no impairment charge related to intangible assets and goodwill.

Cash and Restricted Cash

Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. As of September 30, 2021, and December 31, 2020, the Company had no cash equivalents. As of September 30, 2021, and December 31, 2020, the Company had $0 and $444,845 in restricted cash, respectively, for amounts held in escrow.

The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows.

		September 30,		December 31,
		2021		2020
Cash	$	5,425,913	$	277,738
Restricted cash		-		444,845
Total cash and restricted cash shown in statement of cash flows	$	5,425,913	$	722,583

Major Customers

The Company had two customers that made up 16% and 18%, respectively, of accounts receivable as of September 30, 2021. The Company had two customers that made up 10% and 8%, respectively, of accounts receivable as of December 31, 2020.

For the nine months ended September 30, 2021 and 2020, the Company had one customer that made up 13% and 10% of total revenues, respectively.

Fair value measurements

Accounting Standards Codification (“ASC”)  820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.

The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates.  As of September 30, 2021 and December 31, 2020, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis.

Equity Investments

The Company’s equity investments consist of investment in one private company in which the Company does not have the ability to exercise significant influence over their operating and financial activities. This investment is carried at cost as there is no market for the common stock and LLC membership units, accordingly, no quoted market price is available. The investment is tested for impairment, at least annually, and more frequently upon the occurrences of certain events.

The Company has adopted the provisions of ASU 2016-01 and values the investment using the measurement alternative, defined as cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.

Research and Development

The Company focuses on quality control and development of new products and the improvement of existing products. All cost related to research and development activities are expensed as incurred. During the nine months ended September 30, 2021, research and development cost totaled $1,096,333.

Earnings (loss) per shares

The Company presents both basic and diluted net income (loss) per share on the face of the consolidated statements of operations. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, and using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The only potentially dilutive securities outstanding during the periods presented were the convertible debt, options and warrants.  The following table illustrates the computation of basic and diluted earnings per share (“EPS”) for the three and nine months ended September 30, 2021 and 2020:

		For the Three Months Ended September 30, 2021				For the Three Months Ended September 30, 2020
		Net Income	Shares		Per Share Amount		Net loss	Shares		Per Share Amount
Basic EPS
Net income (loss)	$	2,481,592	166,964,408	$	0.01	$	(1,399,862)	131,934,084	$	(0.01)
Effect of Dilutive Securities
Stock options and warrants		-	1,663,499		-		-	-		-
Dilute EPS
Net income (loss) plus
assumed conversions	$	2,481,592	168,627,907	$	0.01	$	(1,399,862)	131,934,084	$	(0.01)

		For the Nine Months Ended September 30, 2021				For the Nine Months Ended September 30, 2020
		Net loss	Shares		Per Share Amount		Net loss	Shares		Per Share Amount
Basic EPS
Net loss	$	(6,775,153)	161,118,324	$	(0.04)	$	(3,712,388)	130,111,673	$	(0.03)
Effect of Dilutive Securities
Convertible debt		-	-		-		(1,557,294)	8,126,877		(0.01)
Dilute EPS
Net loss plus
assumed conversions	$	(6,775,153)	161,118,324	$	(0.04)	$	(5,269,682)	138,238,550	$	(0.04)

XML

Note 3 - Leases

9 Months Ended

Sep. 30, 2021

Notes

Note 3 - Leases

Note 3 – Leases

The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company must discount lease payments based on an estimate of its incremental borrowing rate.

As of September 30, 2021, the future minimum finance and operating lease payments were as follows:

		Finance		Operating
Twelve Months Ending September 30,		Leases		Leases
2022	$	1,895,925	$	175,319
2023		1,923,246		104,648
2024		1,946,100		106,680
2025		1,911,278		53,848
2026		1,859,102		-
Thereafter		17,239,539		-
Total payments		26,775,190		440,495
Less: imputed interest		(10,656,923)		(85,606)
Total obligation		16,118,267		354,889
Less: current portion		(628,574)		(135,207)
Non-current financing leases obligations	$	15,489,693	$	219,682

As of October 1, 2020, the American Precision Fabricators, Inc. (“APF”) building lease with Harbor Island Properties, LLC was modified, assignment was transferred to Excel Fabrication, LLC (“Excel”), and Quality Circuit Assembly, Inc. (“QCA”). As part of the modification, the lease was extended through 2037 and the payment terms were amended effective January 15, 2021. As a result of this amendment, the Company remeasured the finance lease liability and recorded an additional $279,287 to the related asset and finance lease liability on the date of the modification.

Operating Leases

The table below presents the lease related assets and liabilities recorded on the Company’s consolidated balance sheets as of September 30, 2021, and December 31, 2020:

			September 30,		December 31,
	Classification on Balance Sheet		2021		2020
Assets
Operating lease assets	Operating lease right of use assets	$	347,712	$	581,311
Total lease assets		$	347,712	$	581,311
Liabilities
Current liabilities
Operating lease liability	Current operating lease liability	$	135,207	$	334,500
Noncurrent liabilities
Operating lease liability	Long-term operating lease liability		219,682		269,030
Total lease liability		$	354,889	$	603,530

On May 3, 2021, the Company entered into a lease agreement for the building on 4740 Cleveland in Ft. Myers, Fl. The lease has a term of 72 months with monthly payments ranging from $40,833 to $49,583 from May 2021-July 2021 and $58,333 from August 2021 through the end of the term. The Company determined the lease to be an operating lease and recognized a right-of-use asset and operating lease liability of $3,689,634 based on the present value of the minimum lease payments discounted using an incremental borrowing rate of 3.96%. This lease was terminated on August 27, 2021, when the Company purchased the building.

At September 30, 2021 and December 31, 2020, the weighted average remaining lease terms were 2.88 and 2.98 years; respectively, and the weighted average discount rates were 15% and 15%, respectively.

XML

Note 4 - Notes Payable and Line of Credit

9 Months Ended

Sep. 30, 2021

Notes

Note 4 - Notes Payable and Line of Credit

Note 4 – Notes Payable and Line of Credit

The outstanding balances for the loans as of September 30, 2021, and December 31, 2020, were as follows:

		September 30,		December 31,
		2021		2020
Lines of credit, current portion	$	3,718,972	$	2,819,793
Equipment loans, current portion		63,531		245,388
PPP loans		278,867		-
Term notes, current portion		5,468,843		4,035,730
Total current		9,530,213		7,100,911
PPP/EIDL loans		877,083		4,340,956
Long-term portion of equipment loans and term notes		6,645,379		10,860,494
Total notes payable and line of Credit	$	17,052,675	$	22,302,361

Future scheduled maturities of outstanding notes payable are as follows:

Twelve Months Ending September 30,
2022	$	9,530,212
2023		933,846
2024		2,183,157
2025		125,699
2026		130,755
Thereafter		4,149,006
Total	$	17,052,675

During the nine months ended September 30, 2021, the Company received forgiveness on nine loans under the Paycheck Protection Program (“PPP”) of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act. The Company recognized a gain on forgiveness of debt of $4,896,573.   

In connection with the Deluxe acquisition in November 2019, the Company issued two subordinated secured promissory notes to the seller.  The first note for $1,900,000 bears interest at 4.25% per annum, require monthly payment for the first 35 months of $19,463 with any remaining principal and accrued interest due on the 3 year-anniversary.  The second note for $496,343 bore interest at 8.75% matured in January 2020 and was fully settled through a debt conversion agreement with the seller.  On April 8, 2021, the Company entered into a settlement agreement with the seller wherein the outstanding balance on the first note amounting to $1,883,418 including accrued interest and net other costs was settled in full through a payment of approximately $887,000 and the exchange of 1,617,067 shares of the Company’s Class C common shares held by the seller for the same number of shares of the Company’s Class A common stock. The Company recognized a gain on extinguishment of debt totaling $803,079 during the nine months ended September 30, 2021, as a result of the settlement of the note.

In August 2020, the company filed a lawsuit against Alan Martin regarding his note payable (See Note 11). As of September 30, 2021, the note had a balance of $2,857,500 and accrued interest of $1,091,212 which is reflective in the current liabilities.

During 2021, the Company entered into three revolving lines of credit totaling $8.3 million and two capital expenditures lines of credit totaling $1.0 million. The revolving lines of credit used as of September 30, 2021, totaled $3.7 million with an interest rate ranging from prime plus 2.50% - 4.25% and a term of one year. As of September 30, 2021, the Company had $5.6 in additional funds available to borrow.

On August 27, 2021 the Company entered into $4.7 million agreement for the purchase of a building located at 4740 Cleveland in Ft. Myers, Florida. The loan bears interest at a rate of 3.95% per annum for a term of 10 years and requires monthly payments of $24,574. The loan is secured by the building and a guarantee by the Company. As of September 30, 2021, there were no payments made for this loan as the initial payment was due in October 2021, and subsequent payments are due by the 27th of each month. As of the date of this Report, the Company was current with this obligation.

XML

Note 5 - Notes Payable, Related Parties

9 Months Ended

Sep. 30, 2021

Notes

Note 5 - Notes Payable, Related Parties

Note 5 – Notes Payable, Related Parties

At September 30, 2021, and December 31, 2020, notes payable due to related parties consisted of the following:

		September 30,		December 31,
		2021		2020
Notes payable; non-interest bearing; due upon demand; unsecured	$	3,000	$	3,000
Series of notes payable, bearing interest at rates from 0% to 20% per annum, with maturity dates from April 2018 to July 2021, unsecured		-		235,651
Total notes payable - related parties	$	3,000	$	238,651

Two non-interest-bearing notes totaling $3,000 were in default as of September 30, 2021. These notes were due on demand by the lenders as of the date of this Report.

XML

Note 6 - Convertible Notes Payable

9 Months Ended

Sep. 30, 2021

Notes

Note 6 - Convertible Notes Payable

Note 6 – Convertible Notes Payable

At September 30, 2021, and December 31, 2020, convertible notes payable consisted of the following:

		September 30,		December 31,
		2021		2020
Series of convertible notes payable issued prior to December 31, 2016, bearing interest at rates of 8% - 10% per annum, with due dates ranging from December 2016 through June 2017.  The outstanding principal and interest balances are convertible into shares of Class A common stock at the option of the debt holder at exercise price of $1 per share.	$	7,500	$	25,000
Secured convertible notes payable issued to the sellers of QCA on April 1, 2016 for an aggregate of $2,000,000, bearing interest at 5% per annum, due in monthly payments starting on July 1, 2016 and due in full on July 1, 2019.  On August 6 and 11, 2019, the Company extended the due date of the two notes to December 31, 2020 and December 31, 2022, respectively.  In May and June 2020, these convertible notes were amended — see (A) below. The outstanding principal and interest balances were fully paid during the nine months ended September 30, 2021.		-		1,291,463
On December 7, 2018, the Company entered into a variable convertible note for $130,000 with net proceeds of $122,200.  The note is due September 7, 2019 and bears interest at 12% per annum.  The note is immediately convertible into shares of the Company's Class A common stock at a discount of 40% to the lowest trading closing prices of the stock for 20 days prior to conversion. This note was amended in November 2019 to increase the principal amount by $180,000 due to penalty interest; increase the interest rate to 15% and effect a floor in the conversion price of $0.15 per share. The outstanding principal and interest balance of the note was converted during the nine months ended September 30, 2021.		-		7,538
On November 14, 2019, the Company issued a convertible note for $200,000.  The note is due November 13, 2020 and bears interest at 15% per annum.  The note is immediately convertible into shares of the Company's Class A common stock at a fixed price of $0.15 per share. The outstanding principal balance of the note was converted during the nine months ended September 30, 2021.		-		200,000
In December 2020 and January 2021, the Company issued convertible notes to individual investors totaling to $1,890,500.  The notes are due three to six months from the date of issuance; accrue interest at 5 – 6.25% per annum and are convertible into shares of the Company's Class A common stock at a fixed rate of $0.25 to $3.00. The outstanding principal balance of the notes were converted during the nine months ended September 30, 2021.		-		1,482,500
Total convertible notes payable		7,500		3,006,501
Less: discount on convertible notes payable		-		(1,343,624)
Total convertible notes payable, net of discount		7,500		1,662,877
Less: current portion of convertible notes payable		(7,500)		(562,242)
Long-term portion of convertible notes payable	$	-	$	1,100,635

In May and June 2020 the Company amended the following seller notes:

-The convertible note with Jeff Moss with a $720,185 balance as of May 4, 2020, was amended to extend the maturity date to May 4, 2027, at 5% interest with weekly payments of $2,605.   The principal balance was increased to $798,800 and the balance outstanding at December 31, 2020, was $735,329.  

-The convertible note with Dwight Hargreaves with a $551,001 balance as of June 5, 2020, was amended to extend the maturity date to June 5, 2026, at 6% interest with weekly payments of $2,316.  The principal balance was increased to $605,464 and the balance outstanding at September 30, 2021 and December 31, 2020, was $0 and $556,135, respectively.   

A loss on extinguishment of debt of $192,272 was recognized on these transactions in June 2020.   

During the nine months ended September 30, 2021, and the year ended December 31, 2020, the Company issued convertible notes with fixed conversion prices.  The Company recognized a beneficial conversion feature related to these convertible notes amounting to $92,428 and $1,482,500 for the nine months ended September 30, 2021, and the year ended December 31, 2020, respectively, as a debt discount to the convertible notes and as a component of equity.  The discounts are being amortized over the terms of the convertible notes payable.  Amortization of debt discounts during the nine months ended September 30, 2021 and 2020, amounted to $1,436,052 and $507,534, respectively, and is recorded as interest expense in the accompanying consolidated statements of operations.  There was no remaining unamortized discount balance for these notes as of September 30, 2021.

A summary of the activity in the Company's convertible notes payable is provided below:

Balance outstanding, December 31, 2020	$	1,662,877
Issuance of convertible notes payable for cash		408,000
Repayment of notes		(1,680,964)
Conversion of notes payable to common stock		(1,726,037)
Amortization of debt discounts		1,436,052
Discount from beneficial conversion feature		(92,428)
Balance outstanding, September 30, 2021	$	7,500

XML

Note 7 - Stockholders' Equity

9 Months Ended

Sep. 30, 2021

Notes

Note 7 - Stockholders' Equity

Note 7 – Stockholders' Equity

Common Stock

The Company had the following transactions in its common stock during the nine months ended September 30, 2021:

·On February 11, 2021, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors to purchase 8,333,333 shares of the Company’s Class A common stock for aggregate gross proceeds of approximately $50 million.  A.G.P./Alliance Global Partners served as the placement agent and received a cash fee of 7% of the aggregate gross proceeds and warrants to purchase shares of the Company’s Class A Common Stock equal to 5% of the number of shares sold in the offering with an exercise price of $6.60 per share and are not exercisable until August 16, 2021. Net proceeds from the sale of shares amounted to approximately $45 million.  

·In February 2021, the Company issued 1,524,064 shares of Class A common stock to an investor for cash for total proceeds of $9.3 million.   

·During the nine months ended September 30, 2021, the Company issued 7,384,018 shares of Class A common stock for the conversion of total debt and accrued liabilities totaling $1,886,898.   

·On March 17, 2021, the Company repurchased 45,000 shares of Class C common stock for $185,850.  

·On May 5, 2021, the Company issued 281,223 shares of Class A common stock that were valued at $1,102,394 in connection with the acquisition of TDI. 

·On May 10, 2021, the Company issued 361,787 shares of Class A common stock that were valued at $1,432,677 in connection with the acquisition of Alt Labs. 

·On April 30, 2021, the Company issued 1,617,067 shares of Class A common stock for no additional consideration upon conversion of that number of shares of Class C common stock by the holder of the Class C common stock. 

·On May 17, 2021, the Company issued 350,000 shares of Class A common stock for no additional consideration upon conversion of that number of shares of Class B common stock by the holder of the Class B common stock. 

Preferred Stock

·On February 8, 2021, the Company issued 1,432,244 shares of Series D Preferred Stock in connection with the acquisition of assets of Vayu that were valued at $6,653,309.  

·In March 2021, the Company repurchased 514,286 outstanding restricted stock units (RSUs) which had not yet settled, from two individuals in privately negotiated transactions. The Company repurchased 314,286 shares of Series C Preferred Stock and 200,000 shares of Series D Preferred Stock at $3.50 per share. The RSUs had been issued to the individuals in connection with the IA and Vayu acquisitions. 

Stock Options

The following summarizes the stock option activity for the nine months ended September 30, 2021:

				Weighted-
			Weighted-	Average
			Average	Remaining		Aggregate
			Exercise	Contractual		Intrinsic
	Options		Price	Life (Years)		Value
Outstanding at December 31, 2020	1,790,000	$	0.19	7.09	$	6,176,855
Granted	-
Forfeited	-
Exercised	-
Outstanding at September 30, 2021	1,790,000	$	0.19	6.34	$	3,599,255
Vested and expected to vest
at September 30, 2021	1,790,000	$	0.19	6.34	$	3,599,255
Exercisable at September 30, 2021	1,556,126	$	0.21	6.27	$	3,097,221

The following table summarizes information about options outstanding and exercisable as of September 30, 2021:

	Options Outstanding			Options Exercisable
		Weighted	Weighted		Weighted
		Average	Average		Average
Exercise	Number	Remaining	Exercise	Number	Exercise
Price	of Shares	Life (Years)	Price	of Shares	Price
0.05	979,000	6.88	0.05	761,063	0.05
0.10	85,000	6.53	0.10	69,063	0.10
0.13	388,500	5.84	0.13	388,500	0.13
0.26	114,000	5.59	0.26	114,000	0.26
0.90	223,500	5.52	0.90	223,500	0.90
	1,790,000			1,556,126

During the nine months ended September 30, 2021 and 2020, stock option expense amounted to $31,933 and $58,887, respectively. Unrecognized stock option expense as of September 30, 2021, amounted to $11,815, which will be recognized over a period extending through December 2022.    

Warrants

The following summarizes the warrants activity for the nine months ended September 30, 2021:

				Weighted-
			Weighted-	Average
			Average	Remaining		Aggregate
			Exercise	Contractual		Intrinsic
	Warrants		Price	Life (Years)		Value
Outstanding at December 31, 2020	275,000	$	1.01	0.23	$	723,250
Granted	416,667		6.60
Forfeited	(275,000)		1.01
Exercised	-
Outstanding at September 30, 2021	416,667	$	6.60	3.39	$	-
Vested and expected to vest
at September 30, 2021	416,667	$	6.60	3.39	$	-
Exercisable at September 30, 2021	-	$	-	-	$	-

The following table summarizes information about warrants outstanding and exercisable as of September 30, 2021:

		Warrants Outstanding				Warrants Exercisable
			Weighted		Weighted			Weighted
			Average		Average			Average
	Exercise	Number	Remaining		Exercise	Number		Exercise
	Price	of Shares	Life (Years)		Price	of Shares		Price
$	6.60	416,667	3.39	$	6.60	-	$	-
		416,667				-

During the nine months ended September 30, 2021, the Company issued 416,667 warrants to a placement agent in connection with sale of its common stock. The warrants have an exercise price of $6.60, are exercisable as of August 16, 2021 and expire on February 16, 2025.

The fair value of the 416,667 warrants, issued to the placement agent during the nine months ended September 30, 2021, of $2,498,637 was determined using the Black-Scholes option pricing model with the following assumptions:

Stock price	$6.00
Risk-free interest rate	0.01%
Expected life of the options	4 years
Expected volatility	347%
Expected dividend yield	0%

The fair value of the warrants was recorded as offering costs with a corresponding credit to additional paid in capital.

XML

Note 8 - Business Combination

9 Months Ended

Sep. 30, 2021

Notes

Note 8 - Business Combination

Note 8 – Business Combinations

Vayu (US)

Effective February 8, 2021, the Company purchased the assets of Vayu (US), Inc., a Delaware corporation (“Vayu”).

Under the provision of ASC 805, the Company had to determine whether this acquisition was a business combination or an asset (or a group of assets) acquisition. In doing so, the Company determined that the acquisition of Vayu was in fact an asset purchase.  Of the consideration given for the Vayu acquisition more than 95% was concentrated in a single asset or a group of assets in Intellectual Property. As such, the Company accounted for this acquisition as an asset acquisition in accordance with ASC 805-10-20.  Accordingly, the assets acquired are initially recognized at the consideration paid, which was the fair value of the series D preferred stock issued, including direct acquisition costs, of which there were none. The cost is allocated to the group of assets acquired based on their relative fair values. The assets acquired and liabilities assumed were as follows at the acquisition date:

		Purchase Allocation
Cash	$	81,442
Property and equipment		50,000
Intellectual property		6,981,256
Non-solicitation covenant		90,000
Accrued expenses and other current liabilities		(411,539)
SBA loan (PPP funds)		(137,850)
	$	6,653,309

The purchase price was paid as follows:

Series D Preferred Stock	$	6,653,309
	$	6,653,309

TDI

On May 5, 2021, the Company closed on the acquisition of Thermal Dynamics, Inc., a Delaware corporation. This acquisition was considered an acquisition of a business under ASC 805. A summary of the purchase price allocation at fair value is below. The business combination accounting is not yet complete and the amounts assigned to assets acquired and liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as information is obtained about facts and circumstances that existed at the acquisition date.

		Purchase Allocation
Accounts receivable	$	1,408,682
Contract assets		826,231
Property and equipment		111,789
Intangible assets		4,820,000
Goodwill		3,528,621
Accounts payable		(786,151)
Accrued expenses and other current liabilities		(53,857)
Contract liability		(2,334,188)
Notes payable		(64,733)
	$	7,456,394

The purchase price was paid as follows:

Class A Common Stock	$	1,102,394
Cash		6,354,000
	$	7,456,394

Alt Labs

On May 10, 2021, the Company closed on the acquisition of Alternative Laboratories, LLC., a Delaware limited liability company. This acquisition was considered an acquisition of a business under ASC 805. A summary of the purchase price allocation at fair value is below. The business combination accounting is not yet complete and the amounts assigned to assets acquired and liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as information is obtained about facts and circumstances that existed at the acquisition date.

		Purchase Allocation
Accounts receivable	$	397,441
Inventory		2,621,653
Property and equipment		1,739,441
Intangible assets		10,410,000
Goodwill		252,851
Other asset		390,502
Accounts payable		(397,441)
Accrued expenses and other current liabilities		(62,242)
Contract liability		(1,754,290)
Noted payable		(1,695,238)
	$	11,902,677

The purchase price was paid as follows:

Class A Common Stock	$	1,432,677
Cash		10,470,000
	$	11,902,677

On May 4, 2021, the Company also entered into an agreement to acquire the 100% membership interest in 4740 Cleveland LLC (“Cleveland”), a Florida limited liability company that is the owner of the building currently being leased by Alt Labs, for a total purchase price of $7,000,000. In connection with this agreement, the Company placed in escrow the amount of $1,400,000 which will be applied to the purchase price upon closing. The Company closed on the purchase of the building in August 2021.

The following are the unaudited pro forma results of operations for the nine months ended September 30, 2021 and 2020, as if Excel, Impossible Aerospace, Inc. (“IA”), Vayu, TDI, and Alt Labs had been acquired on January 1, 2020.  The pro forma results include estimates and assumptions which management believes are reasonable.  However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of these entities, and are not necessarily indicative of the results that would have occurred if the business combination had been in effect on the dates indicated.

		Pro Forma Combined Financials (unaudited)
		Three Months Ended September 30,				Nine Months Ended September 30,
		2021		2020		2021		2020
Sales	$	17,398,316	$	16,299,024	$	49,465,682	$	51,377,078
Cost of goods sold		12,104,134		12,020,468		35,183,907		37,090,187
Gross profit		5,294,182		4,278,556		14,281,775		14,286,891
Operating expenses		6,966,642		4,855,978		21,474,825		17,294,094
Loss from operations		(1,672,460)		(577,422)		(7,193,050)		(3,007,203)
Net income (loss)		2,481,592		(809,618)		(3,892,897)		(2,742,963)
Net income (loss) per share		0.01		(0.01)		(0.02)		(0.02)

XML

Note 9 - Equity Investments

9 Months Ended

Sep. 30, 2021

Notes

Note 9 - Equity Investments

Note 9 – Equity Investments

AmplifeiIntl LLC

On September 15, 2021, A4 Manufacturing, Inc. entered into a Membership Interest Purchase Agreement acquiring approximately a 9% membership interest in AmplifeiIntl LLC (also doing business as Happinss), a Texas limited liability company. The membership interest is non-voting and the Company does not have the ability to exercise significant influence over operating and financial activities. The equity investment is being valued using cost as there is no market for the membership units, and accordingly, no quoted market price is available. The investment is tested for impairment, at least annually, and more frequently upon the occurrences of certain events. As of September 30, 2021, the Company determined there was no impairment.

The membership interest was paid for as follows:    

Accounts receivable converted	$	1,000,000
Cash		350,000
Total	$	1,350,000

XML

Note 10 - Segment Reporting

9 Months Ended

Sep. 30, 2021

Notes

Note 10 - Segment Reporting

Note 10 – Segment Reporting

The Company discloses segment information that is consistent with the way in which management operates and views its business.  Effective during the quarter ended September 30, 2021, the Company has reduced its reportable segments to four operating segments as represented by the Company’s four silos: A4 Construction Services, Inc.; A4 Manufacturing, Inc.; A4 Aerospace Corporation; and A4 Defense Systems, Inc.  The Company’s reportable segments for the three and nine months ended September 30, 2021, and September 30, 2020, and as of September 30, 2021 and December 31, 2020:

			Three Months Ended September 30,				Nine Months Ended September 30,
			2021		2020		2021		2020
Revenue
	Construction Services	$	5,465,881	$	5,488,718	$	15,565,332	$	17,198,134
	Manufacturing		10,210,549		3,240,915		21,506,262		9,409,959
	Defense		1,721,886		-		2,866,991		-
		$	17,398,316	$	8,729,633	$	39,938,585	$	26,608,093
Gross profit
	Construction Services	$	678,702	$	343,965	$	1,392,904	$	2,753,554
	Manufacturing		3,128,290		995,262		6,672,549		2,301,433
	Defense		641,144		-		1,101,362		-
		$	4,448,136	$	1,339,227	$	9,166,815	$	5,054,987
Income (loss) from operations
	Construction Services	$	(607,794)	$	(529,896)	$	(3,464,327)	$	(195,470)
	Manufacturing		947,792		392,029		1,679,930		(886,867)
	Aerospace		(963,134)		-		(3,886,311)		-
	Defense		(135,575)		-		(131,953)		-
	Unallocated		(913,749)		(434,184)		(3,846,085)		(2,199,556)

		$	(1,672,460)	$	(572,051)	$	(9,648,746)	$	(3,281,893)
Depreciation and amortization
	Construction Services	$	240,966	$	389,269	$	995,014	$	1,099,834
	Manufacturing		469,419		153,271		1,049,042		455,714
	Aerospace		222,291		-		448,659		-
	Defense		87,322		-		143,539		-
	Unallocated		158,807		10,520		215,715		27,056
		$	1,178,805	$	553,060	$	2,851,969	$	1,582,604
Interest Expense
	Construction Services	$	150,028	$	567,206	$	832,498	$	1,723,594
	Manufacturing		113,910		233,283		382,785		615,436
	Defense		-		-		825		-
	Unallocated		273,944		338,973		2,010,084		1,355,501
		$	537,882	$	1,139,462	$	3,226,192	$	3,694,531
Net income (loss)
	Construction Services	$	1,792,912	$	(1,027,073)	$	(881,293)	$	(1,240,693)
	Manufacturing		2,913,757		400,368		3,371,416		(1,145,527)
	Aerospace		(963,134)		-		(3,456,780)		-
	Defense		(120,481)		-		(114,097)		-
	Unallocated		(1,141,462)		(773,157)		(5,694,399)		(1,326,168)
		$	2,481,592	$	(1,399,862)	$	(6,775,153)	$	(3,712,388)

			As of September 30, 2021		As of December 31, 2020
Total Assets
	Construction Services	$	16,681,507	$	22,648,181
	Manufacturing		43,804,926		10,731,936
	Aerospace		14,332,809		6,342,863
	Defense		11,319,049		-
	Unallocated		10,973,041		1,011,203
		$	97,111,332	$	40,734,183
Goodwill
	Construction Services	$	121,221	$	121,221
	Manufacturing		2,216,612		1,963,761
	Defense		3,528,621		-
		$	5,866,454	$	2,084,982
Accounts receivable, net
	Construction Services	$	4,793,691	$	4,501,401
	Manufacturing		7,205,449		1,983,468
	Defense		991,089		-
		$	12,990,229	$	6,484,869

XML

Note 11 - Commitments and Contingencies

9 Months Ended

Sep. 30, 2021

Notes

Note 11 - Commitments and Contingencies

Note 11 – Commitments and Contingencies

Legal Proceedings

From time to time, the Company may become involved in lawsuits and other legal proceedings that arise in the course of business. Litigation is subject to inherent uncertainties, and it is not possible to predict the outcome of litigation with total confidence. As of the date of this Report, the Company was not aware of any legal proceedings or potential claims against it whose outcome would be likely, individually or in the aggregate, to have a material adverse effect on the Company’s business, financial condition, operating results, or cash flows, except as set forth below.

In June 2020, the Company’s subsidiary Excel Fabrication, LLC filed a lawsuit against Fusion Mechanical, LLC, in the Fifth Judicial District Court, State of Idaho (Case Number CV42-20-2246). The Company claimed tortious interference and trade secret violations by the defendant.  The defendant filed a motion to dismiss, which was denied by the Court. The defendant filed a second motion to dismiss and the Company filed a memorandum in response to the second motion to dismiss, for which a hearing was held on May 10, 2021. On June 11, 2021, the court issued a decision narrowing the claims of the plaintiffs to three items, breach of contract, good faith and fair dealings, and intentional interference for economic advantage. These were the Company’s three main points of contention. As of the date of this Report, discovery was proceeding. The Company intends to pursue vigorously its claims.

In August 2020, the Company filed a lawsuit, in the United States District Court, District of Arizona (Case No.2:20-cv-01679-DJH), against Alan Martin, the seller of Horizon Well Testing LLC (“HWT”) dba Venture West Energy Services, LLC. The Company brought claims for breach of contract, including but not limited to breaches of the seller’s representations and warranties in the purchase agreement in connection with the acquisition of HWT.  The defendant answered and counterclaimed, claiming breach by the Company of its obligation to issue a promissory note (to be issued in connection with the acquisition of HWT). The parties have engaged in discovery and settlement negotiations, both of which were ongoing as of the date of this Report. Additionally, a settlement conference is scheduled for November 18, 2021.

In May 2021, the Company and several shareholders filed a lawsuit, in the United States District Court for the District of Arizona (Case number 2:21-cv-00886-MTL) against Fin Capital LLC ("Fin Cap"), and Grizzly Research LLC ("Grizzly") alleging securities fraud, tortious interference with business expectancy and libel and slander for disseminating false and misleading statements about Alpine 4 and its employees to manipulate the stock price and further their own financial interests.

XML

Note 12 - Subsequent Events

9 Months Ended

Sep. 30, 2021

Notes

Note 12 - Subsequent Events

Note 12 – Subsequent Events

On November 1, 2021, the Company issued 2,506,249 shares of Class A common stock for no additional consideration upon conversion of 1,652,591 shares of Series C Preferred Stock and 1,432,244 shares of Series D Preferred Stock into Class A Common Stock, pursuant to the respective Certificates of Designation of the Series C and Series D Preferred Stock.

Identified Technologies Corporation

On October 20, 2021, the Company and the Company’s subsidiary, A4 Aerospace, Inc., a Delaware corporation (the “Buyer”), entered into a Stock Purchase Agreement (the “SPA”) with Identified Technologies Corporation, a Delaware corporation with foreign registration in Pennsylvania (the “Target”), and all of the shareholders of the Target: Birchmere Ventures 5 LP; Xalisco Ventures; Richard Zhang; Ashok Trivedi; Sunil Wadhwani; Innovation Works, Inc.; Startbot LLC; 2008 Mark Zappala IRR Trust; Birchmere Labs I LP; Cimax Partners I; Wu-Yang Family Trust; Zappala Family LP; and AT Gekko PR (each a “Shareholder” and collectively, the “Shareholders”).

Pursuant to the SPA, the Buyer purchased all of the outstanding shares of capital stock of the Target, a total of 6,486,044 shares of the Target’s capital stock (the “Target Shares”). The total purchase price for the Target Shares was $4,000,000 and was paid in shares of the Company’s Class A common stock (the “Company Shares”), issued to the Shareholders. Following the closing of the transaction, the Buyer owned 100% of the capital stock of the Target. The acquisition of the Target closed on October 20, 2021.

A total of 888,881 shares of restricted Class A common stock with a fair value of approximately $3.6 million were issued to the 13 Shareholders, together with an aggregate of $35.47 in cash (to avoid the issuance of fractional shares). Pursuant to the SPA, the Shareholders were limited to being able to sell 33% of their shares every 90 days once the Shares were no longer restricted pursuant to Rule 144.

XML

Note 2 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)

9 Months Ended

Sep. 30, 2021

Policies

Principles of Consolidation

Principles of consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of September 30, 2021 and December 31, 2020.  Significant intercompany balances and transactions have been eliminated.

XML

Note 2 - Summary of Significant Accounting Policies: Use of Estimates, Policy (Policies)

9 Months Ended

Sep. 30, 2021

Policies

Use of Estimates, Policy

Use of estimates

The consolidated financial statements are prepared in accordance with U.S. GAAP.  Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. In many instances, the Company could have reasonably used different accounting estimates and in other instances changes in the accounting estimates are reasonably likely to occur from period to period. This applies in particular to useful lives of long-lived assets, valuation allowance for deferred tax assets and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial

statement presentation, financial condition, results of operations and cash flows will be affected.  The ultimate impact from COVID-19 on the Company’s operations and financial results during 2021 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, and the speed with which the economy recovers. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during 2021 and beyond.  COVID-19 did have a negative impact on the Company’s financial performance in 2020.  During the nine months ended September 30, 2021, there was no impairment charge related to intangible assets and goodwill.

XML

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash (Policies)

9 Months Ended

Sep. 30, 2021

Policies

Cash and Restricted Cash

Cash and Restricted Cash

Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. As of September 30, 2021, and December 31, 2020, the Company had no cash equivalents. As of September 30, 2021, and December 31, 2020, the Company had $0 and $444,845 in restricted cash, respectively, for amounts held in escrow.

The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows.

		September 30,		December 31,
		2021		2020
Cash	$	5,425,913	$	277,738
Restricted cash		-		444,845
Total cash and restricted cash shown in statement of cash flows	$	5,425,913	$	722,583

XML

Note 2 - Summary of Significant Accounting Policies: Major Customers (Policies)

9 Months Ended

Sep. 30, 2021

Policies

Major Customers

Major Customers

The Company had two customers that made up 16% and 18%, respectively, of accounts receivable as of September 30, 2021. The Company had two customers that made up 10% and 8%, respectively, of accounts receivable as of December 31, 2020.

For the nine months ended September 30, 2021 and 2020, the Company had one customer that made up 13% and 10% of total revenues, respectively.

XML

Note 2 - Summary of Significant Accounting Policies: Fair Value Measurement (Policies)

9 Months Ended

Sep. 30, 2021

Policies

Fair Value Measurement

Fair value measurements

Accounting Standards Codification (“ASC”)  820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.

The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.

The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates.  As of September 30, 2021 and December 31, 2020, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis.

XML

Note 2 - Summary of Significant Accounting Policies: Equity Investments (Policies)

9 Months Ended

Sep. 30, 2021

Policies

Equity Investments

Equity Investments

The Company’s equity investments consist of investment in one private company in which the Company does not have the ability to exercise significant influence over their operating and financial activities. This investment is carried at cost as there is no market for the common stock and LLC membership units, accordingly, no quoted market price is available. The investment is tested for impairment, at least annually, and more frequently upon the occurrences of certain events.

The Company has adopted the provisions of ASU 2016-01 and values the investment using the measurement alternative, defined as cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.

XML

Note 2 - Summary of Significant Accounting Policies: Research and Development (Policies)

9 Months Ended

Sep. 30, 2021

Policies

Research and Development

Research and Development

The Company focuses on quality control and development of new products and the improvement of existing products. All cost related to research and development activities are expensed as incurred. During the nine months ended September 30, 2021, research and development cost totaled $1,096,333.

XML

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) per share (Policies)

9 Months Ended

Sep. 30, 2021

Policies

Earnings (loss) per share

Earnings (loss) per shares

The Company presents both basic and diluted net income (loss) per share on the face of the consolidated statements of operations. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, and using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The only potentially dilutive securities outstanding during the periods presented were the convertible debt, options and warrants.  The following table illustrates the computation of basic and diluted earnings per share (“EPS”) for the three and nine months ended September 30, 2021 and 2020:

		For the Three Months Ended September 30, 2021				For the Three Months Ended September 30, 2020
		Net Income	Shares		Per Share Amount		Net loss	Shares		Per Share Amount
Basic EPS
Net income (loss)	$	2,481,592	166,964,408	$	0.01	$	(1,399,862)	131,934,084	$	(0.01)
Effect of Dilutive Securities
Stock options and warrants		-	1,663,499		-		-	-		-
Dilute EPS
Net income (loss) plus
assumed conversions	$	2,481,592	168,627,907	$	0.01	$	(1,399,862)	131,934,084	$	(0.01)

		For the Nine Months Ended September 30, 2021				For the Nine Months Ended September 30, 2020
		Net loss	Shares		Per Share Amount		Net loss	Shares		Per Share Amount
Basic EPS
Net loss	$	(6,775,153)	161,118,324	$	(0.04)	$	(3,712,388)	130,111,673	$	(0.03)
Effect of Dilutive Securities
Convertible debt		-	-		-		(1,557,294)	8,126,877		(0.01)
Dilute EPS
Net loss plus
assumed conversions	$	(6,775,153)	161,118,324	$	(0.04)	$	(5,269,682)	138,238,550	$	(0.04)

XML

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash: Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table

		September 30,		December 31,
		2021		2020
Cash	$	5,425,913	$	277,738
Restricted cash		-		444,845
Total cash and restricted cash shown in statement of cash flows	$	5,425,913	$	722,583

XML

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) per share: Schedule of Earnings Per Share, Basic and Diluted (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Earnings Per Share, Basic and Diluted

		For the Three Months Ended September 30, 2021				For the Three Months Ended September 30, 2020
		Net Income	Shares		Per Share Amount		Net loss	Shares		Per Share Amount
Basic EPS
Net income (loss)	$	2,481,592	166,964,408	$	0.01	$	(1,399,862)	131,934,084	$	(0.01)
Effect of Dilutive Securities
Stock options and warrants		-	1,663,499		-		-	-		-
Dilute EPS
Net income (loss) plus
assumed conversions	$	2,481,592	168,627,907	$	0.01	$	(1,399,862)	131,934,084	$	(0.01)

		For the Nine Months Ended September 30, 2021				For the Nine Months Ended September 30, 2020
		Net loss	Shares		Per Share Amount		Net loss	Shares		Per Share Amount
Basic EPS
Net loss	$	(6,775,153)	161,118,324	$	(0.04)	$	(3,712,388)	130,111,673	$	(0.03)
Effect of Dilutive Securities
Convertible debt		-	-		-		(1,557,294)	8,126,877		(0.01)
Dilute EPS
Net loss plus
assumed conversions	$	(6,775,153)	161,118,324	$	(0.04)	$	(5,269,682)	138,238,550	$	(0.04)

XML

Note 3 - Leases: Schedule of Future Minimum Lease Payments for Capital Leases (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Future Minimum Lease Payments for Capital Leases

		Finance		Operating
Twelve Months Ending September 30,		Leases		Leases
2022	$	1,895,925	$	175,319
2023		1,923,246		104,648
2024		1,946,100		106,680
2025		1,911,278		53,848
2026		1,859,102		-
Thereafter		17,239,539		-
Total payments		26,775,190		440,495
Less: imputed interest		(10,656,923)		(85,606)
Total obligation		16,118,267		354,889
Less: current portion		(628,574)		(135,207)
Non-current financing leases obligations	$	15,489,693	$	219,682

XML

Note 3 - Leases: Schedule of Right of Use Assets and Lease Liabilities (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Right of Use Assets and Lease Liabilities

			September 30,		December 31,
	Classification on Balance Sheet		2021		2020
Assets
Operating lease assets	Operating lease right of use assets	$	347,712	$	581,311
Total lease assets		$	347,712	$	581,311
Liabilities
Current liabilities
Operating lease liability	Current operating lease liability	$	135,207	$	334,500
Noncurrent liabilities
Operating lease liability	Long-term operating lease liability		219,682		269,030
Total lease liability		$	354,889	$	603,530

XML

Note 4 - Notes Payable and Line of Credit: Schedule of Notes Payable (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Notes Payable

		September 30,		December 31,
		2021		2020
Lines of credit, current portion	$	3,718,972	$	2,819,793
Equipment loans, current portion		63,531		245,388
PPP loans		278,867		-
Term notes, current portion		5,468,843		4,035,730
Total current		9,530,213		7,100,911
PPP/EIDL loans		877,083		4,340,956
Long-term portion of equipment loans and term notes		6,645,379		10,860,494
Total notes payable and line of Credit	$	17,052,675	$	22,302,361

XML

Note 4 - Notes Payable and Line of Credit: Future Scheduled Maturities Of Outstanding Notes Payable To Third Parties (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Future Scheduled Maturities Of Outstanding Notes Payable To Third Parties

Twelve Months Ending September 30,
2022	$	9,530,212
2023		933,846
2024		2,183,157
2025		125,699
2026		130,755
Thereafter		4,149,006
Total	$	17,052,675

XML

Note 5 - Notes Payable, Related Parties: Schedule of Notes Payable, Related Parties (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Notes Payable, Related Parties

		September 30,		December 31,
		2021		2020
Notes payable; non-interest bearing; due upon demand; unsecured	$	3,000	$	3,000
Series of notes payable, bearing interest at rates from 0% to 20% per annum, with maturity dates from April 2018 to July 2021, unsecured		-		235,651
Total notes payable - related parties	$	3,000	$	238,651

XML

Note 6 - Convertible Notes Payable: Schedule of Convertible Notes Payable (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Convertible Notes Payable

		September 30,		December 31,
		2021		2020
Series of convertible notes payable issued prior to December 31, 2016, bearing interest at rates of 8% - 10% per annum, with due dates ranging from December 2016 through June 2017.  The outstanding principal and interest balances are convertible into shares of Class A common stock at the option of the debt holder at exercise price of $1 per share.	$	7,500	$	25,000
Secured convertible notes payable issued to the sellers of QCA on April 1, 2016 for an aggregate of $2,000,000, bearing interest at 5% per annum, due in monthly payments starting on July 1, 2016 and due in full on July 1, 2019.  On August 6 and 11, 2019, the Company extended the due date of the two notes to December 31, 2020 and December 31, 2022, respectively.  In May and June 2020, these convertible notes were amended — see (A) below. The outstanding principal and interest balances were fully paid during the nine months ended September 30, 2021.		-		1,291,463
On December 7, 2018, the Company entered into a variable convertible note for $130,000 with net proceeds of $122,200.  The note is due September 7, 2019 and bears interest at 12% per annum.  The note is immediately convertible into shares of the Company's Class A common stock at a discount of 40% to the lowest trading closing prices of the stock for 20 days prior to conversion. This note was amended in November 2019 to increase the principal amount by $180,000 due to penalty interest; increase the interest rate to 15% and effect a floor in the conversion price of $0.15 per share. The outstanding principal and interest balance of the note was converted during the nine months ended September 30, 2021.		-		7,538
On November 14, 2019, the Company issued a convertible note for $200,000.  The note is due November 13, 2020 and bears interest at 15% per annum.  The note is immediately convertible into shares of the Company's Class A common stock at a fixed price of $0.15 per share. The outstanding principal balance of the note was converted during the nine months ended September 30, 2021.		-		200,000
In December 2020 and January 2021, the Company issued convertible notes to individual investors totaling to $1,890,500.  The notes are due three to six months from the date of issuance; accrue interest at 5 – 6.25% per annum and are convertible into shares of the Company's Class A common stock at a fixed rate of $0.25 to $3.00. The outstanding principal balance of the notes were converted during the nine months ended September 30, 2021.		-		1,482,500
Total convertible notes payable		7,500		3,006,501
Less: discount on convertible notes payable		-		(1,343,624)
Total convertible notes payable, net of discount		7,500		1,662,877
Less: current portion of convertible notes payable		(7,500)		(562,242)
Long-term portion of convertible notes payable	$	-	$	1,100,635

XML

Note 6 - Convertible Notes Payable: Schedule of Acitivity of Convertible Notes Payable (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Acitivity of Convertible Notes Payable

Balance outstanding, December 31, 2020	$	1,662,877
Issuance of convertible notes payable for cash		408,000
Repayment of notes		(1,680,964)
Conversion of notes payable to common stock		(1,726,037)
Amortization of debt discounts		1,436,052
Discount from beneficial conversion feature		(92,428)
Balance outstanding, September 30, 2021	$	7,500

XML

Note 7 - Stockholders' Equity: Schedule of Common Stock Outstanding Roll Forward (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Common Stock Outstanding Roll Forward

				Weighted-
			Weighted-	Average
			Average	Remaining		Aggregate
			Exercise	Contractual		Intrinsic
	Options		Price	Life (Years)		Value
Outstanding at December 31, 2020	1,790,000	$	0.19	7.09	$	6,176,855
Granted	-
Forfeited	-
Exercised	-
Outstanding at September 30, 2021	1,790,000	$	0.19	6.34	$	3,599,255
Vested and expected to vest
at September 30, 2021	1,790,000	$	0.19	6.34	$	3,599,255
Exercisable at September 30, 2021	1,556,126	$	0.21	6.27	$	3,097,221

The following table summarizes information about options outstanding and exercisable as of September 30, 2021:

	Options Outstanding			Options Exercisable
		Weighted	Weighted		Weighted
		Average	Average		Average
Exercise	Number	Remaining	Exercise	Number	Exercise
Price	of Shares	Life (Years)	Price	of Shares	Price
0.05	979,000	6.88	0.05	761,063	0.05
0.10	85,000	6.53	0.10	69,063	0.10
0.13	388,500	5.84	0.13	388,500	0.13
0.26	114,000	5.59	0.26	114,000	0.26
0.90	223,500	5.52	0.90	223,500	0.90
	1,790,000			1,556,126

XML

Note 7 - Stockholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Stockholders' Equity Note, Warrants or Rights

The following summarizes the warrants activity for the nine months ended September 30, 2021:

				Weighted-
			Weighted-	Average
			Average	Remaining		Aggregate
			Exercise	Contractual		Intrinsic
	Warrants		Price	Life (Years)		Value
Outstanding at December 31, 2020	275,000	$	1.01	0.23	$	723,250
Granted	416,667		6.60
Forfeited	(275,000)		1.01
Exercised	-
Outstanding at September 30, 2021	416,667	$	6.60	3.39	$	-
Vested and expected to vest
at September 30, 2021	416,667	$	6.60	3.39	$	-
Exercisable at September 30, 2021	-	$	-	-	$	-

XML

Note 7 - Stockholders' Equity: Schedule Of Summary Of Warrants Outstanding And Exercisable (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule Of Summary Of Warrants Outstanding And Exercisable

The following table summarizes information about warrants outstanding and exercisable as of September 30, 2021:

		Warrants Outstanding				Warrants Exercisable
			Weighted		Weighted			Weighted
			Average		Average			Average
	Exercise	Number	Remaining		Exercise	Number		Exercise
	Price	of Shares	Life (Years)		Price	of Shares		Price
$	6.60	416,667	3.39	$	6.60	-	$	-
		416,667				-

XML

Note 7 - Stockholders' Equity: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of the 416,667 warrants, issued to the placement agent during the nine months ended September 30, 2021, of $2,498,637 was determined using the Black-Scholes option pricing model with the following assumptions:

Stock price	$6.00
Risk-free interest rate	0.01%
Expected life of the options	4 years
Expected volatility	347%
Expected dividend yield	0%

XML

Note 8 - Business Combination: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Tables)

9 Months Ended

Sep. 30, 2021

Vayu US

Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination

		Purchase Allocation
Cash	$	81,442
Property and equipment		50,000
Intellectual property		6,981,256
Non-solicitation covenant		90,000
Accrued expenses and other current liabilities		(411,539)
SBA loan (PPP funds)		(137,850)
	$	6,653,309

The purchase price was paid as follows:

Series D Preferred Stock	$	6,653,309
	$	6,653,309

TDI

Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination

		Purchase Allocation
Accounts receivable	$	1,408,682
Contract assets		826,231
Property and equipment		111,789
Intangible assets		4,820,000
Goodwill		3,528,621
Accounts payable		(786,151)
Accrued expenses and other current liabilities		(53,857)
Contract liability		(2,334,188)
Notes payable		(64,733)
	$	7,456,394

The purchase price was paid as follows:

Class A Common Stock	$	1,102,394
Cash		6,354,000
	$	7,456,394

Alt Labs

Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination

		Purchase Allocation
Accounts receivable	$	397,441
Inventory		2,621,653
Property and equipment		1,739,441
Intangible assets		10,410,000
Goodwill		252,851
Other asset		390,502
Accounts payable		(397,441)
Accrued expenses and other current liabilities		(62,242)
Contract liability		(1,754,290)
Noted payable		(1,695,238)
	$	11,902,677

The purchase price was paid as follows:

Class A Common Stock	$	1,432,677
Cash		10,470,000
	$	11,902,677

XML

Note 8 - Business Combination: Business Acquisition, Pro Forma Information (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Business Acquisition, Pro Forma Information

		Pro Forma Combined Financials (unaudited)
		Three Months Ended September 30,				Nine Months Ended September 30,
		2021		2020		2021		2020
Sales	$	17,398,316	$	16,299,024	$	49,465,682	$	51,377,078
Cost of goods sold		12,104,134		12,020,468		35,183,907		37,090,187
Gross profit		5,294,182		4,278,556		14,281,775		14,286,891
Operating expenses		6,966,642		4,855,978		21,474,825		17,294,094
Loss from operations		(1,672,460)		(577,422)		(7,193,050)		(3,007,203)
Net income (loss)		2,481,592		(809,618)		(3,892,897)		(2,742,963)
Net income (loss) per share		0.01		(0.01)		(0.02)		(0.02)

XML

Note 9 - Equity Investments: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Tables)

9 Months Ended

Sep. 30, 2021

AmplifeiIntl LLC

Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination

Accounts receivable converted	$	1,000,000
Cash		350,000
Total	$	1,350,000

XML

Note 10 - Segment Reporting: Schedule of Segment Reporting Information, by Segment (Tables)

9 Months Ended

Sep. 30, 2021

Tables/Schedules

Schedule of Segment Reporting Information, by Segment

			Three Months Ended September 30,				Nine Months Ended September 30,
			2021		2020		2021		2020
Revenue
	Construction Services	$	5,465,881	$	5,488,718	$	15,565,332	$	17,198,134
	Manufacturing		10,210,549		3,240,915		21,506,262		9,409,959
	Defense		1,721,886		-		2,866,991		-
		$	17,398,316	$	8,729,633	$	39,938,585	$	26,608,093
Gross profit
	Construction Services	$	678,702	$	343,965	$	1,392,904	$	2,753,554
	Manufacturing		3,128,290		995,262		6,672,549		2,301,433
	Defense		641,144		-		1,101,362		-
		$	4,448,136	$	1,339,227	$	9,166,815	$	5,054,987
Income (loss) from operations
	Construction Services	$	(607,794)	$	(529,896)	$	(3,464,327)	$	(195,470)
	Manufacturing		947,792		392,029		1,679,930		(886,867)
	Aerospace		(963,134)		-		(3,886,311)		-
	Defense		(135,575)		-		(131,953)		-
	Unallocated		(913,749)		(434,184)		(3,846,085)		(2,199,556)

		$	(1,672,460)	$	(572,051)	$	(9,648,746)	$	(3,281,893)
Depreciation and amortization
	Construction Services	$	240,966	$	389,269	$	995,014	$	1,099,834
	Manufacturing		469,419		153,271		1,049,042		455,714
	Aerospace		222,291		-		448,659		-
	Defense		87,322		-		143,539		-
	Unallocated		158,807		10,520		215,715		27,056
		$	1,178,805	$	553,060	$	2,851,969	$	1,582,604
Interest Expense
	Construction Services	$	150,028	$	567,206	$	832,498	$	1,723,594
	Manufacturing		113,910		233,283		382,785		615,436
	Defense		-		-		825		-
	Unallocated		273,944		338,973		2,010,084		1,355,501
		$	537,882	$	1,139,462	$	3,226,192	$	3,694,531
Net income (loss)
	Construction Services	$	1,792,912	$	(1,027,073)	$	(881,293)	$	(1,240,693)
	Manufacturing		2,913,757		400,368		3,371,416		(1,145,527)
	Aerospace		(963,134)		-		(3,456,780)		-
	Defense		(120,481)		-		(114,097)		-
	Unallocated		(1,141,462)		(773,157)		(5,694,399)		(1,326,168)
		$	2,481,592	$	(1,399,862)	$	(6,775,153)	$	(3,712,388)

			As of September 30, 2021		As of December 31, 2020
Total Assets
	Construction Services	$	16,681,507	$	22,648,181
	Manufacturing		43,804,926		10,731,936
	Aerospace		14,332,809		6,342,863
	Defense		11,319,049		-
	Unallocated		10,973,041		1,011,203
		$	97,111,332	$	40,734,183
Goodwill
	Construction Services	$	121,221	$	121,221
	Manufacturing		2,216,612		1,963,761
	Defense		3,528,621		-
		$	5,866,454	$	2,084,982
Accounts receivable, net
	Construction Services	$	4,793,691	$	4,501,401
	Manufacturing		7,205,449		1,983,468
	Defense		991,089		-
		$	12,990,229	$	6,484,869

XML

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash: Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Details
Cash	$ 5,425,913	$ 277,738
Restricted Cash	0	444,845
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 5,425,913	$ 722,583

XML

Note 2 - Summary of Significant Accounting Policies: Major Customers (Details)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Accounts Receivable Concentration Risk
Concentration Risk, Customer	The Company had two customers that made up 16% and 18%, respectively, of accounts receivable	The Company had two customers that made up 10% and 8%, respectively, of accounts receivable
Revenues Concentration Risk
Concentration Risk, Customer	the Company had one customer that made up 13% and 10% of total revenues, respectively.

XML

Note 2 - Summary of Significant Accounting Policies: Research and Development (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Research and development	$ 581,131	$ 0	$ 1,096,333	$ 0

XML

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) per share: Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Net income (loss)	$ 2,481,592	$ (3,127,277)	$ (6,129,468)	$ (1,399,862)	$ (2,562,914)	$ 250,388	$ (6,775,153)	$ (3,712,388)
Weighted Average Number of Shares Outstanding, Basic	166,964,408			131,934,084			161,118,324	130,111,673
Earnings Per Share, Basic	$ 0.01			$ (0.01)			$ (0.04)	$ (0.03)
Dilutive Securities, Effect on Basic Earnings Per Share							$ 1,663,499	$ 8,126,877
Net Income (Loss) Attributable to Parent, Diluted	$ 2,481,592			$ (1,399,862)			$ (6,775,153)	$ (5,269,682)
Weighted Average Number of Shares Outstanding, Diluted	168,627,907			131,934,084			161,118,324	138,238,550
Earnings Per Share, Diluted	$ 0.01			$ (0.01)			$ (0.04)	$ (0.04)
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities								$ (1,557,294)
Dilutive Securities, per share								$ (0.01)

XML

Note 3 - Leases: Schedule of Future Minimum Lease Payments for Capital Leases (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Finance Lease, Liability, to be Paid, Year One	$ 1,895,925
Lessee, Operating Lease, Liability, to be Paid, Year One	175,319
Finance Lease, Liability, to be Paid, Year Two	1,923,246
Lessee, Operating Lease, Liability, to be Paid, Year Two	104,648
Finance Lease, Liability, to be Paid, Year Three	1,946,100
Lessee, Operating Lease, Liability, to be Paid, Year Three	106,680
Finance Lease, Liability, to be Paid, Year Four	1,911,278
Lessee, Operating Lease, Liability, to be Paid, Year Four	53,848
Finance Lease, Liability, to be Paid, Year Five	1,859,102
Lessee, Operating Lease, Liability, to be Paid, Year Five	0
Finance Lease, Liability, to be Paid, after Year Five	17,239,539
Lessee, Operating Lease, Liability, to be Paid, after Year Five	0
Finance Lease, Liability, Payment, Due	26,775,190
Lessee, Operating Lease, Liability, to be Paid	440,495
Finance Lease, Liability	16,118,267
Operating Lease, Liability	354,889	$ 603,530
Financing lease obligation, current portion	(628,574)	(639,527)
Operating lease obligation, current portion	(135,207)	(334,500)
Financing lease obligations, net of current portion	15,489,693	15,687,176
Operating lease obligations, net of current portion	219,682	$ 269,030
Finance Leases
Imputed Interest on Capital Lease	(10,656,923)
Operating Leases
Imputed Interest on Capital Lease	$ (85,606)

XML

Note 3 - Leases (Details) - USD ($)	2 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Jul. 31, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Remeasurement of finance lease liability			$ 279,287	$ 0
Monthly Operating Lease Obligation	$ 58,333
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$ 3,689,634		$ 3,689,634
Operating Lease, Weighted Average Remaining Lease Term	2 years 10 months 17 days		2 years 10 months 17 days		2 years 11 months 23 days
Operating Lease, Weighted Average Discount Rate, Percent	15.00%		15.00%		15.00%
Minimum
Monthly Operating Lease Obligation		$ 40,833
Maximum
Monthly Operating Lease Obligation		$ 49,583

XML

Note 3 - Leases: Schedule of Right of Use Assets and Lease Liabilities (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Details
Right of use assets, net	$ 347,712	$ 581,311
Operating lease obligation, current portion	135,207	334,500
Operating lease obligations, net of current portion	219,682	269,030
Operating Lease, Liability	$ 354,889	$ 603,530

XML

Note 4 - Notes Payable and Line of Credit: Schedule of Notes Payable (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Notes and Loans Payable, Current	$ 9,530,213	$ 7,100,911
Notes Payable	17,052,675	22,302,361
Lines of Credit
Notes and Loans Payable, Current	3,718,972	2,819,793
Equipment Loans
Notes and Loans Payable, Current	63,531	245,388
PPP/EIDL Loans
Notes and Loans Payable, Current	278,867	0
Long-term Debt	877,083	4,340,956
Short Term Notes
Notes and Loans Payable, Current	5,468,843	4,035,730
Equipment, Noncurrent
Long-term Debt	$ 6,645,379	$ 10,860,494

XML

Note 4 - Notes Payable and Line of Credit: Future Scheduled Maturities Of Outstanding Notes Payable To Third Parties (Details)	9 Months Ended
	Sep. 30, 2021 USD ($)
Details
Future Maturities of Outstanding Notes Payable, Third Parties, Remainder of Current Year	$ 9,530,212
Future Maturities of Outstanding Notes Payable, Third Parties, Year Two	933,846
Future Maturities of Outstanding Notes Payable, Third Parties, Year Three	2,183,157
Future Maturities of Outstanding Notes Payable, Third Parties, Year Four	125,699
Future Maturities of Outstanding Notes Payable, Third Parties, Year Five	130,755
Future Maturities of Outstanding Notes Payable, Third Parties, Thereafter	4,149,006
Future Maturities of Outstanding Notes Payable, Third Parties	$ 17,052,675

XML

Note 4 - Notes Payable and Line of Credit (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Nov. 30, 2019	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Apr. 08, 2021
Gain on forgiveness of debt		$ 4,307,291	$ 0	$ 4,896,573	$ 0
Gain (loss) on extinguishment of debt		0	$ 253,063	$ 803,079	$ 344,704
Line of Credit Facility, Borrowing Capacity, Description				During 2021, the Company entered into three revolving lines of credit totaling $8.3 million and two capital expenditures lines of credit totaling $1.0 million. The revolving lines of credit used as of September 30, 2021, totaled $3.7 million with an interest rate ranging from prime plus 2.50% - 4.25% and a term of one year. As of September 30, 2021, the Company had $5.6 in additional funds available to borrow.
Line of Credit Facility, Remaining Borrowing Capacity		$ 5,600,000		$ 5,600,000
Subordinated Secured Promissory Note 1
Debt Instrument, Face Amount	$ 1,900,000					$ 1,883,418
Debt Instrument, Interest Rate During Period	4.25%
Debt Instrument, Periodic Payment	$ 19,463
Subordinated Secured Promissory Note 2
Debt Instrument, Face Amount	$ 496,343
Debt Instrument, Interest Rate During Period	8.75%

XML

Note 5 - Notes Payable, Related Parties: Schedule of Notes Payable, Related Parties (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Notes payable, related parties	$ 3,000	$ 238,651
Notes Payable 1
Notes payable, related parties	3,000	3,000
Notes Payable 2
Notes payable, related parties	$ 0	$ 235,651

XML

Note 6 - Convertible Notes Payable: Schedule of Convertible Notes Payable (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Convertible Notes Payable	$ 7,500	$ 3,006,501
Debt Instrument, Unamortized Discount	0	(1,343,624)
Convertible Notes Payable, net of discount	7,500	1,662,877
Convertible notes payable, current	(7,500)	(562,242)
Convertible notes payable, net of current portion	0	1,100,635
Convertible Notes Payable 1
Convertible Notes Payable	7,500	25,000
Convertible Notes Payable 2
Convertible Notes Payable	0	1,291,463
Convertible Notes Payable 3
Convertible Notes Payable	0	7,538
Convertible Notes Payable 4
Convertible Notes Payable	0	200,000
Convertible Notes Payable 5
Convertible Notes Payable	$ 0	$ 1,482,500

XML

Note 6 - Convertible Notes Payable (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 05, 2020	May 04, 2020
Convertible Notes Payable	$ 7,500			$ 3,006,501
Gain (Loss) on Extinguishment of Debt	803,079	$ 344,704
Debt Instrument, Convertible, Beneficial Conversion Feature	92,428	1,482,500
Amortization of debt discounts	$ 1,436,052	$ 507,534
Jeff Moss
Debt Instrument, Face Amount			$ 798,800			$ 720,185
Debt Conversion, Converted Instrument, Expiration or Due Date	May 04, 2027
Debt Instrument, Interest Rate During Period	5.00%
Debt Instrument, Periodic Payment	$ 2,605
Convertible Notes Payable				735,329
Dwight Hargreaves
Debt Instrument, Face Amount			$ 605,464		$ 551,001
Debt Conversion, Converted Instrument, Expiration or Due Date		Jun. 05, 2026
Debt Instrument, Interest Rate During Period		6.00%
Debt Instrument, Periodic Payment		$ 2,316
Convertible Notes Payable	$ 0			$ 556,135
Gain (Loss) on Extinguishment of Debt		$ 192,272

XML

Note 6 - Convertible Notes Payable: Schedule of Acitivity of Convertible Notes Payable (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Details
Convertible Notes Payable, net of discount	$ 7,500		$ 1,662,877
Issuance of convertible notes payable for cash	408,000
Repayments of convertible notes payable	(1,680,964)	$ (270,294)
Conversion of notes payable to common stock	(1,726,037)
Amortization of debt discounts	1,436,052	$ 507,534
Discount from beneficial conversion feature	$ (92,428)

XML

Note 7 - Stockholders' Equity (Details) - USD ($)		3 Months Ended					9 Months Ended
	Feb. 11, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Proceeds from the sale of common stock, net of offering costs							$ 54,302,982	$ 374,000
Stock Issued During Period, Value, New Issues					$ 124,000	$ 250,000
Stock Issued During Period, Value, Acquisitions			$ 2,535,071	$ 6,653,309
Stock price		$ 6.00					$ 6.00
Employee stock compensation							$ 31,933	$ 58,887
Unrecognized Stock Option Expense		$ 11,815					$ 11,815
Restricted Stock Units (RSUs)
Stock Repurchased During Period, Shares							514,286
TDI
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 7,456,394
Alt Labs
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							11,902,677
Vayu US
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 6,653,309
Common Class A
Stock Issued During Period, Shares, New Issues					3,000,000	3,941,753
Stock Issued During Period, Value, New Issues					$ 300	$ 394
Stock Issued During Period, Shares, Acquisitions			643,010
Conversion of Class C to Class A, Shares		1,617,067	1,617,067
Conversion of Class C to Class A, Shares		(1,617,067)	(1,617,067)
Conversion of Class B to Class A, Shares		350,000	350,000
Conversion of Class B to Class A, Shares		(350,000)	(350,000)
Stock Issued During Period, Value, Acquisitions			$ 64	0
Common Class A | TDI
Stock Issued During Period, Shares, Acquisitions							281,223
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 1,102,394
Common Class A | Alt Labs
Stock Issued During Period, Shares, Acquisitions							361,787
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 1,432,677
Common Class A | Investor
Stock Issued During Period, Shares, New Issues							1,524,064
Stock Issued During Period, Value, New Issues							$ 9,300,000
Stock Issued During Period, Shares, Conversion of Convertible Securities							7,384,018
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments							$ 1,886,898
Common Class C
Stock Issued During Period, Value, New Issues					0	0
Conversion of Class C to Class A, Shares		(1,617,067)	(1,617,067)
Conversion of Class C to Class A, Shares		1,617,067	1,617,067
Stock Issued During Period, Value, Acquisitions			$ 0	0
Common Class C | Investor
Stock Repurchased During Period, Shares							45,000
Stock Repurchased During Period, Value							$ 185,850
Common Class B
Stock Issued During Period, Value, New Issues					0	0
Conversion of Class B to Class A, Shares		(350,000)	(350,000)
Conversion of Class B to Class A, Shares		350,000	350,000
Stock Issued During Period, Value, Acquisitions			$ 0	$ 0
Series D Preferred Stock
Stock Issued During Period, Value, New Issues					0	0
Stock Issued During Period, Shares, Acquisitions				1,432,244
Stock Issued During Period, Value, Acquisitions			0	$ 143
Series D Preferred Stock | Vayu US
Stock Repurchased During Period, Shares							200,000
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income							$ 6,653,309
Stock price		$ 3.50					$ 3.50
Series C Preferred Stock
Stock Issued During Period, Value, New Issues					$ 0	$ 0
Stock Issued During Period, Value, Acquisitions			$ 0	$ 0
Series C Preferred Stock | Vayu US
Stock Repurchased During Period, Shares							314,286
Purchase Agreement
Sale of stock	8,333,333
Proceeds from the sale of common stock, net of offering costs	$ 45,000,000

XML

Note 7 - Stockholders' Equity: Schedule of Common Stock Outstanding Roll Forward (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	1,790,000
Exercisable	1,556,126
Equity Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	1,790,000		1,790,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.19		$ 0.19
Weighted Average Remaining Contractual Term, Outstanding	6 years 4 months 2 days	7 years 1 month 2 days
Outstanding, Intrinsic Value	$ 3,599,255		$ 6,176,855
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	0
Forfeited	0
Vested and expected to vest	1,790,000
Weighted average price per share - Vested and Expected to Vest	$ 0.19
Weighted Average Remaining Contractual Term, Vested and Expected to Vest	6 years 4 months 2 days
Outstanding, Intrinsic Value, Vested and Expected to Vest	$ 3,599,255
Exercisable	1,556,126
Weighted average price per share - Exercisable	$ 0.21
Outstanding, Intrinsic Value, Exercisable	$ 3,097,221
Stock Option 1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	979,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.05
Weighted Average Remaining Contractual Term, Outstanding	6 years 10 months 17 days
Exercisable	761,063
Weighted average price per share - Exercisable	$ 0.05
Stock Option 2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	85,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.10
Weighted Average Remaining Contractual Term, Outstanding	6 years 6 months 10 days
Exercisable	69,063
Weighted average price per share - Exercisable	$ 0.10
Stock Option 3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	388,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.13
Weighted Average Remaining Contractual Term, Outstanding	5 years 10 months 2 days
Exercisable	388,500
Weighted average price per share - Exercisable	$ 0.13
Stock Option 4
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	114,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.26
Weighted Average Remaining Contractual Term, Outstanding	5 years 7 months 2 days
Exercisable	114,000
Weighted average price per share - Exercisable	$ 0.26
Stock Option 5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	223,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.90
Weighted Average Remaining Contractual Term, Outstanding	5 years 6 months 7 days
Exercisable	223,500
Weighted average price per share - Exercisable	$ 0.90

XML

Note 7 - Stockholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Details) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Outstanding		1,790,000
Exercisable		1,556,126
Warrant
Outstanding	275,000	275,000
Weighted average price per share	$ 1.01	$ 1.01
Weighted Average Remaining Contractual Term, Outstanding	3 years 4 months 20 days		2 months 23 days
Outstanding, Intrinsic Value	$ 0		$ 723,250
Granted		416,667
Weighted average price per share - Granted		$ 6.60
Forfeited		(275,000)
Weighted average price per share - Forfeited		$ 1.01
Exercised		0
Outstanding		416,667	275,000
Weighted average price per share		$ 6.60	$ 1.01
Vested and expected to vest		416,667
Weighted average price per share - Vested and Expected to Vest		$ 6.60
Weighted Average Remaining Contractual Term, Vested and Expected to Vest		3 years 4 months 20 days
Outstanding, Intrinsic Value, Vested and Expected to Vest		$ 0
Exercisable		0
Weighted average price per share - Exercisable		$ 0
Outstanding, Intrinsic Value, Exercisable		$ 0

XML

Note 7 - Stockholders' Equity: Schedule Of Summary Of Warrants Outstanding And Exercisable (Details)	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Outstanding, Intrinsic Value, Exercisable	416,667
Warrants Exercisable	0
Warrant 2
Outstanding, Intrinsic Value, Exercisable	416,667
Warrants Exercisable	3 years 4 months 20 days
Warrants Outstanding, Weighted Average Exercise Price | $ / shares	$ 6.60
Warrants Exercisable	0
Warrants Exercisable, Weighted Average Exercise Price | $ / shares	$ 0

XML

Note 7 - Stockholders' Equity: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	9 Months Ended
	Sep. 30, 2021 $ / shares
Details
Stock price	$ 6.00
Risk-free interest rate	0.01%
Expected life of the options	4 years
Expected volatility	347.00%
Expected dividend yield	0.00%

XML

Note 8 - Business Combination: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Details)	9 Months Ended
	Sep. 30, 2021 USD ($)
Vayu US
Cash	$ 81,442
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	50,000
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Intellectual Property	6,981,256
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Non-Solicitation Covenant	90,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other	(411,539)
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Loan	(137,850)
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,653,309
Cash	(81,442)
Vayu US | Series D Preferred Stock
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,653,309
TDI
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	7,456,394
TDI | Business Acquisition, Accounts Receivable
Cash	1,408,682
Cash	(1,408,682)
TDI | Business Acquisition, Contract Asset
Cash	826,231
Cash	(826,231)
TDI | Business Acquisition, Property and Equipment
Cash	111,789
Cash	(111,789)
TDI | Business Acquisition Intangible Assets
Cash	4,820,000
Cash	(4,820,000)
TDI | Business Acquisition, Goodwill
Cash	3,528,621
Cash	(3,528,621)
TDI | Business Acquisition, Accounts Payable
Cash	786,151
Cash	(786,151)
TDI | Business Acquisition, Accrued Expenses
Cash	53,857
Cash	(53,857)
TDI | Business Acquisition, Contract liability
Cash	2,334,188
Cash	(2,334,188)
TDI | Business Acquisition, Notes Payable
Cash	64,733
Cash	(64,733)
TDI | Business Acquisition, Cash
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,354,000
TDI | Common Class A
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	1,102,394
Alt Labs
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	11,902,677
Alt Labs | Business Acquisition, Accounts Receivable
Cash	397,441
Cash	(397,441)
Alt Labs | Business Acquisition, Property and Equipment
Cash	1,739,441
Cash	(1,739,441)
Alt Labs | Business Acquisition Intangible Assets
Cash	10,410,000
Cash	(10,410,000)
Alt Labs | Business Acquisition, Goodwill
Cash	252,851
Cash	(252,851)
Alt Labs | Business Acquisition, Accounts Payable
Cash	397,441
Cash	(397,441)
Alt Labs | Business Acquisition, Accrued Expenses
Cash	62,242
Cash	(62,242)
Alt Labs | Business Acquisition, Contract liability
Cash	1,754,290
Cash	(1,754,290)
Alt Labs | Business Acquisition, Notes Payable
Cash	1,695,238
Cash	(1,695,238)
Alt Labs | Business Acquisition, Cash
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	10,470,000
Alt Labs | Business Acquisition, Inventory
Cash	2,621,653
Cash	(2,621,653)
Alt Labs | Business Acquisition, Other Asset
Cash	390,502
Cash	(390,502)
Alt Labs | Common Class A
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	$ 1,432,677

XML

Note 8 - Business Combination: Business Acquisition, Pro Forma Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Sales	$ 17,398,316	$ 16,299,024	$ 49,465,682	$ 51,377,078
Cost of goods sold	12,104,134	12,020,468	35,183,907	37,090,187
Gross profit	5,294,182	4,278,556	14,281,775	14,286,891
Operating Expenses	6,966,642	4,855,978	21,474,825	17,294,094
Loss from operations	(1,672,460)	(577,422)	(7,193,050)	(3,007,203)
Net loss	$ 2,481,592	$ (809,618)	$ (3,892,897)	$ (2,742,963)
Loss per share	$ 0.01	$ (0.01)	$ (0.02)	$ (0.02)

XML

Note 9 - Equity Investments: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Details) - AmplifeiIntl LLC	Sep. 30, 2021 USD ($)
Business Acquisition, Accounts Receivable Converted
Cash	$ 1,000,000
Business Acquisition, Cash
Cash	$ 350,000

XML

Note 10 - Segment Reporting: Schedule of Segment Reporting Information, by Segment (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Construction Services
Revenue	$ 5,465,881			$ 5,488,718			$ 15,565,332	$ 17,198,134
Gross Profit	678,702			343,965			1,392,904	2,753,554
Loss from operations	(607,794)			(529,896)			(3,464,327)	(195,470)
Depreciation, Depletion and Amortization, Nonproduction	240,966			389,269			995,014	1,099,834
Interest Expense	150,028			567,206			832,498	1,723,594
Net income (loss)	1,792,912			(1,027,073)			(881,293)	(1,240,693)
TOTAL ASSETS	16,681,507						16,681,507		$ 22,648,181
Goodwill	121,221						121,221		121,221
Accounts receivable, net	4,793,691						4,793,691		4,501,401
Manufacturing
Revenue	10,210,549			3,240,915			21,506,262	9,409,959
Gross Profit	3,128,290			995,262			6,672,549	2,301,433
Loss from operations	947,792			392,029			1,679,930	(886,867)
Depreciation, Depletion and Amortization, Nonproduction	469,419			153,271			1,049,042	455,714
Interest Expense	113,910			233,283			382,785	615,436
Net income (loss)	2,913,757			400,368			3,371,416	(1,145,527)
TOTAL ASSETS	43,804,926						43,804,926		10,731,936
Goodwill	2,216,612						2,216,612		1,963,761
Accounts receivable, net	7,205,449						7,205,449		1,983,468
Defense
Revenue	1,721,886			0			2,866,991	0
Gross Profit	641,144			0			1,101,362	0
Loss from operations	(135,575)			0			(131,953)	0
Depreciation, Depletion and Amortization, Nonproduction	87,322			0			143,539	0
Interest Expense	0			0			825	0
Net income (loss)	(120,481)			0			(114,097)	0
TOTAL ASSETS	11,319,049						11,319,049		0
Goodwill	3,528,621						3,528,621		0
Accounts receivable, net	991,089						991,089		0
Revenue	17,398,316			8,729,633			39,938,585	26,608,093
Gross Profit	4,448,136			1,339,227			9,166,815	5,054,987
Loss from operations	(1,672,460)			(572,051)			(9,648,746)	(3,281,893)
Depreciation, Depletion and Amortization, Nonproduction	1,178,805			553,060			2,851,969	1,582,604
Interest Expense	537,882			1,139,462			3,226,192	3,694,531
Net income (loss)	2,481,592	$ (3,127,277)	$ (6,129,468)	(1,399,862)	$ (2,562,914)	$ 250,388	(6,775,153)	(3,712,388)
TOTAL ASSETS	97,111,332						97,111,332		40,734,183
Goodwill	5,866,454						5,866,454		2,084,982
Accounts receivable, net	12,990,229						12,990,229		6,484,869
Aerospace
Loss from operations	(963,134)			0			(3,886,311)	0
Depreciation, Depletion and Amortization, Nonproduction	222,291			0			448,659	0
Net income (loss)	(963,134)			0			(3,456,780)	0
TOTAL ASSETS	14,332,809						14,332,809		6,342,863
Unallocated
Loss from operations	(913,749)			(434,184)			(3,846,085)	(2,199,556)
Depreciation, Depletion and Amortization, Nonproduction	158,807			10,520			215,715	27,056
Interest Expense	273,944			338,973			2,010,084	1,355,501
Net income (loss)	(1,141,462)			$ (773,157)			(5,694,399)	$ (1,326,168)
TOTAL ASSETS	$ 10,973,041						$ 10,973,041		$ 1,011,203